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Rheumatoid arthritis is a progressive, destructive and chronic,.inflammatory 
disease of the joint synovium. Signs and symptoms include pain, limited range of 
motion, swelling, and tenderness, which may progress to deformity. These 
manifestations may limit dexterity, independent living, and the overall well being of an 
individual. Living with daily restrictions proves to be a psychologically distressing 
expenence. 
An increase in the dietary boron level of laboratory rats has shown to have a 
positive effect on the range of motion in their involved joints. This concept was tested on 
a human subject at the United States Department of Agriculture's Human Nutrition 
Research Center in Grand Forks, North Dakota over a six-month period from January 9th 
to June 19t\ 2001. Joint involvement was assessed using goniometric measurements, a 
Poly Arthritis form, along with palpation of 16 fibromyalgic points. Subjective 
information was compiled regarding subject's level of pain, stiffness, bogginess, and 
soreness. The subject was measured on a consistent day and time each week. The study 
was conducted under the direction of Dr. Curtiss Hunt at the Human Nutrition Research 
Center and Beverly Johnson PT, MS at the University of North Dakota Department of 
Physical Therapy. Institutional Review Board approval was obtained, and inter-rater and 
intra-rater reliability were established prior to testing. A standardized verbal instruction 
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regimen, to guide the subject and to encourage her to give her maximal effort during 
measurements, was used. 
With an increased intake of boron, a significant influence on the range of motion 
was predicted. It was found, however, the active number of joints for this subject 
remained relatively constant, proving bogginess and soreness/sensitivity to palpation to 
still be present. However, the subjective rating of pain, fibromyalgic points, and hours of 
morning stiffness decreased with boron deprivation. By analyzing the range of motion 
statistics, 21 out of 64 tested motions were found to display changes in the measurements 
of dexterity-related joints for an individual with rheumatoid arthritis between boron 
supplementation and deprivation. A general increase was noted with boron 
supplementation, whereas a decrease was noted in the range of motion with boron 
deprivation. 
The purpose of this case report was to analyze the effect of boron 
supplementation and deprivation and to aid in improving the pathological related signs 
and symptoms of an individual with rheumatoid arthritis. The potential to decrease the 
clinical manifestations and reduce the psychological stress of living with a chronic illness 




"How far you go in life depends on you being tender with the young, compassionate with 
the aged, sympathetic with the striving, and tolerant of the weak and the strong. Because 
some day in life, you will have been all of these. " -George Washington Carver 
"Arthritis limits the activity of over 7 million people and tops heart disease as the 
leading cause of work disability."l Estimates place medical care and lost wages to exceed 
64 billion dollars annually. Rheumatoid arthritis, the most common form of 
inflammatory arthritis, affects 2.5 million Americans? This accounts for approximately 
one percent of the population of the United States, roughly one in 100 people.3 
"Rheumatoid arthritis affects approximately four times as many women as men, and 
symptoms are often first noticed by people between the ages of 25 and 50". There is no 
evidence for environmental factors or an infectious etiology.4 At the present, the etiology 
remains unknown in the research of rheumatoid arthritis. It is known however, that it is a 
progressive, destructive, and chronic, inflammatory disease that affects the synovium and 
connective tissues of the joints. 
The onset of rheumatoid arthritis is frequently insidious and gradua1.4 Clinical 
features of rheumatoid arthritis are manifested in the early stages by joint pain and 
swelling in the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints of 
the hands in a symmetric distribution. The distal interphalangeal joints are often spared. 
Rheumatoid arthritis is a systemic disease; therefore, as progression occurs most of the 
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body's joints are affected. However, the focus of our study was related to dexterity-
related joints of the hands and wrist. Other affected joints will not be of relevance to this 
study. 
Symptoms may include signs of pain, limited range of motion, stiffness, swelling, 
and tenderness.4 A duration of stiffness occurs after prolonged immobility, such as a 
night's rest, and is a common indication of the severity of the inflammation. The initial 
swelling, also referred to as bogginess, is due to an increase in the synovial fluid and may 
be fluctuant. Bogginess can also be characterized, in a more chronic stage, when the 
synovial lining proliferates. 
With deterioration of the joints, rheumatoid arthritis may progress to deformity 
and loss of function. These manifestations may limit dexterity, independent living and 
overall well-being of an individual. Living with daily restrictions proves to be a 
psychologically distressing experience, especially when rheumatoid arthritis displays 
itself with other associated ailments. 
Fibromyalgia often occurs in conjunction with rheumatoid arthritis.4 It is 
characterized by widespread pain and tenderness throughout the body present for a 
minimum of three months and meeting criteria of 11 or more of 18 specific muscular sites 
using approximately four kilograms of force.s The pain resulting as secondary 
complications of rheumatoid arthritis can further limit the capabilities of the individual 
with rheumatoid arthritis. 
Physical and psychological features are prevalent and interwoven in the lives of 
individuals with rheumatoid arthritis. As physical therapists, it is pertinent to understand 
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and monitor these factors to ensure quality care is given in a holistic manner. Treating a 
patient involves awareness of all factors affecting the client. A new approach in 
rheumatoid arthritis treatment may be through the use of boron supplementation. The 
significance of this case report is to demonstrate if a significant change is noted in the 
range of motion of dexterity-related joints in individuals with rheumatoid arthritis 
through boron supplementation. Clinically, as a team member, the therapist must be 
aware of the expanding current knowledge in treatment options to further assist 
individuals living with rheumatoid arthritis. 
The purpose of this scholarly project is to assess the effects of a specified dosage 
of a boron supplement on the physical and emotional manifestations of rheumatoid 
arthritis. Furthermore and more inclusively, this project strived to answer the following 
questions: 1.) Is the range of motion affected in dexterity-related joints through the 
administration of boron? 2.) Is there a significant reduction of the bogginess ancllor 
sensitivity of the dexterity-related joints when a specified level of boron supplement is 
governed? 3.) Does the number of active fibromyalgic points chosen from the assessment 
form significantly alter when boron is administered in a specified dosage? 4.) What 
impact do the physical and psychological aspects have on the physical therapy treatment 
of these individuals? 
Previous research indicates that an increase in the dietary boron level has a 
positive effect on the range of motion of the affected joints in laboratory rats.6 The theory 
of boron's significance in the joints of humans with rheumatoid arthritis has not yet been 
investigated. We propose that factors influenced by the inflammatory process of 
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rheumatoid arthritis including active fibromyalgia points, bogginess, sensitivity, and 
range of motion of the dexterity-related joints of human subjects will be positively 
affected by the increase in dietary boron levels through supplementation. 
CHAPTER II 
REVIEW OF LITERATURE 
Rheumatoid arthritis is a progressive and systemic disease causing deterioration of 
the joints.4 Fibrosis of the synovium often results, causing a decrease in range of motion, 
stiffness, swelling, and possible deformity of the affected joints. Clinical features of 
rheumatoid arthritis are manifested in the early stages by joint pain and swelling. 
With rheumatoid arthritis, the inflammatory process occurring in the joints is also 
accompanied by deposition of immune complexes and rheumatoid factor in the synovial 
lining.4 The synovial lining provides nutritional sources to maintain joint function. As 
the inflammatory process repeatedly occurs, the lining proliferates, joint deformity 
occurs, and a loss of function results. The tendons and ligaments throughout the body 
become deprived of nutrients due to a limited supply of nutrients and therefore, weaken. 
This allows the dexterity-related joints of the hand to retain several deformities 
characteristic of rheumatoid arthritis. These deformities may include boutonniere, swan-
neck deformity, ulnar deviation, and volar subluxation; collectively they will significantly 
interfere with hand function.4 The deformities can be debilitating to the patient's lifestyle. 
The medical field is exploring treatment options for pain management and to decrease 
the impact of functional impairment. 
Evidence has recently supported that the mineral boron increases the range of 
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motion of the joints in laboratory rats and helps control the normal inflammatory 
process.7 In the only reported controlled human study of the interaction between boron, 
used as an oral dietary supplement, and inflammation, 20 patients with confirmed 
osteoarthritis received a placebo or six milligrams of boron for eight weeks in a double-
blind trial. s The arthritic individuals who received boron supplementation reported a 
significant improvement in subjective measures of their condition. 
In 1995, Dr. Curtiss Hunt reported that "ample amounts of dietary boron 
compared to very low amounts significantly delayed the onset of adjuvant-induced 
arthritis in rats".7 It was also demonstrated by Curtiss Hunt that "an animal model shows 
that physiological amounts of boron help control the normal inflammatory process." 
During the latter mentioned, the rats were fed boron low or boron supplemented diets and 
had arthritis induced into the joints through injection of M. butyricum. Signs of 
inflammation and swelling were evident in the contralateral paw to a much greater degree 
with the boron low diet. This suggests that ample amounts of boron may decrease the 
inflammation in joints of laboratory rats. A study was recently initated under the 
supervision of Dr. Hunt, at the North Dakota Department of Agriculture Human Nutrition 
and Research Center in Grand Forks, North Dakota to evaluate the effects of boron 
supplementation and deprivation in the human subject. 
Boron is a micromineral, meaning that the body requires only small periodic 
amounts to fulfill its health needs.9 Boron is a trace mineral found in various foods that 
are consumed daily in the human diet. These include alcoholic beverages, almonds, 
apples, apricots, asparagus, avocados, beets, broccoli, brussel sprouts, cabbage, carrots, 
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cherries, dandelions, dill seed, figs, grape jelly, hazelnuts, legumes, parsley, peaches, 
peanuts, pears, poppy seed, strawberries, squash, and tomatoes.8,9,10 Age and gender 
differences may vary according to the necessary estimated daily intakes. The 
Recommended Daily Allowance established by the Food and Drug Administration is set 
at three milligrams.8 Care must be taken when preparing boron-rich foods, as boiling in 
water or oil quickly decreases boron content. A daily intake of three milligrams of boron 
has been suggested by The Rheumatoid Disease Foundation to assist in treating both 
osteoarthritis and rheumatoid arthritis. 12 
Other uses of boron have been researched. Boron has the ability to replicate 
estrogen in the body.8 As little as three milligrams of boron in the blood has been proven 
to double circulating estrogen levels. 12 This increase in estrogen may relieve multiple 
menopausal symptoms.9, 12 Boron may playa role in osteoarthritis prevention due to the 
ability to replicate estrogen in the body. Osteoporosis may be prevented due to boron's 
capability to overcome low vitamin D3 1evels and prevent bone demineralization. 
Research has also shown that boron may be effective in improving immunology by 
decreasing enzyme activity.1o Mental alertness has been associated with boron-rich 
diets.9 It is apparent that boron may playa vital role in many physiologic activities. 
Boron toxicity, however, is another topic that may need to be addressed with the 
individual with rheumatoid arthritis. Signs of acute boron toxicity include the following: 
nausea, diarrhea, vomiting, headache, hypothermia, weariness, erythema, restlessness, 
renal injury, and death. 10 Excess boron changes the acidity within the system, resulting in 
a loss of electrolyte balance within the body. Consuming excessive amounts of boron 
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around levels of 18-20 grams has proven to be toxic to the human body, however a 
minimal lethal dose has not yet been established. 
The use of boron should not be used as the solitaire treatment. If found to be 
effective, it should be used in conjunction with other treatments. Physical therapy is a 
main component of this multidimensional approach. Treating the individual with 
rheumatoid arthritis may include, but is not limited to, the following: massage, aquatic 
therapy, strengthening, range of motion, aerobic activities, splinting to prevent 
contractures, joint protection, and gait analysis. Exercise has been stated in literature to 
have variable effects on the disease progression within the joint; 13, 14, 15 dynamic exercise 
has been proven beneficial for the preservation of joint integrity. 16 
Anti-inflammatory medication is a vital component to decreasing joint destruction 
and ultimately, deformity for patients with rheumatoid arthritis. As physical therapists, it 
is vital to educate the patient on energy conservation techniques17,18,19 and joint 
protection2o. "Joint protection aims to reduce pain and local inflammation, preserve the 
integrity of joint structures and improve function.,,2o Less traditional treatment 
interventions that patients may combine with their physical therapy intervention in 
controlling their arthritis include herbal remedies21 , massage, acupuncture, and COX-IT 
Inhi bi tors 22. 
By obtaining background knowledge in the rapidly changing medical research 
related to rheumatoid arthritis it will allow for ultimate physical therapy care of 
individuals with rheumatoid arthritis. The therapist may assist them in questions they 
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may have regarding upcoming treatment approaches, referral to proper professionals in 
treatment and nutrition, and supply information regarding nutritional values. 
CHAPTER III 
METHODOLOGY 
Final approval for this scholarly project was granted by the University of North 
Dakota and the United States Department of Agriculture's Human Nutrition Research 
Center in Grand Forks, North Dakota. A copy of the University of North Dakota Human 
Subjects Review Form and specific testing procedures from the USDA Human Nutrition 
Research Center, Grand Forks, North Dakota are included in Appendix C. 
Subjects 
Participants were selected through the USDA Human Nutrition Research Center 
and criteria for this selection can be found in the Participant section of the Human 
Subjects Review Form in Appendix C. Participants were to be women who do not smoke 
or consume alcohol and were diagnosed with chronic rheumatoid arthritis by a physician 
using standard diagnostic procedural criteria. Participation in this study was completely 
voluntary and could be terminated at the request of the subject. An honorarium of 
$5,580.00 was given for participation in the study. The subject was housed at the USDA 
Human Nutrition Research Center in Grand Forks, North Dakota for a total of 168 days 
during the time period of January 3fd , 2001 through June 21 st, 2001. Two subjects 
participated in the study initially, however one subject terminated her participation after 
six weeks. 
A statistical power analysis was conducted; it determined 14 subjects were needed 




Therefore, information from this case report cannot be generalized to the population, and 
results must be viewed as an n=1. The subject receiving boron supplementation in this 
case report was 49 years old at the time of data collection. She wore bilateral wrist 
splints that kept her wrist in approximately 20 degrees of extension with slight radial 
deviation for joint protection. At this facility, the subject was monitored 24 hours a day 
in conjunction with the Human Nutritional Center's policy for subjects to assure 
appropriate experimental control and strict compliance with diet. See Appendix C for the 
IRB. 
The subject was assessed on several clinical tests to measure the psychological, 
physiological, and biomechanical effects of the boron supplementation or deprivation on 
a routine basis. Some of these assessments included the following: hand volume water 
displacement, a psychological questionnaire, medications taken, a nursing assessment, 
and a self-assessment form. Physical therapy was responsible for taking measurements 
with joint assessment, range of motion, fibromyalgic points, pain scales, and an active 
joint count. This case report will be limited to measurements performed by the physical 
therapist and the related data. 
Dietary Boron Supplementation 
Boron content of the diet of our subject was regulated at a basal diet level of 2.0 
milligrams per 2000 kilocalorie for the first 14 days. The estimated boron consumption 
per day of women 60-65 years old is 0.731 milligram. The estimation of 1.95 milligram 
is considered the 95th percentile of women ages 19 and older. See Appendix C. Over the 
course of the next 77 days, the subject received a diet continuing with the 
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supplementation of 2.0 milligrams per 2000 kilocalorie. During the final 77 days, a diet 
with approximately 0.3 milligrams per 2000 kilocalories was administered. 
Range of Motion Measurements 
Range of motion of all dexterity-related joints of the bilateral hands and wrists 
were measured at a consistent time and date each week. Measurements of the DIPs and 
PIPs were assessed with splints donned. Splints were doffed for the following 
measurements: wrist flexion, extension, ulnar deviation, radial deviation, Mep flexion, 
extension of all digits, and thumb IP flexion and extension. Refer to Appendix D for 
exact verbal cues and patient positioning. To assure intra-rater reliability throughout our 
case report range of motion measurements, the subject was measured twice and the 
average of the two measurements was recorded. "In hand goniometry, a plus or minus 
five degree margin of error is accepted even for experienced examiners adhering to 
standardized protocols.,,23 Therefore, if a change greater than five degrees from the 
previous week resulted, the measurement was re-assessed. 
• Goniometric placement for wrist flexion and wrist extension includes the 
fulcrum placed at the ulnar styolid process, the stationary arm bisecting the 
forearm, and the moveable arm placed parallel to the 5th phalange. See 
Figures 1 and 2. 
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Figure 1. Goniometric Placement for Wrist Flexion. 
Figure 2. Goniometric Placement for Wrist Extension. 
• Goniometric placement for ulnar and radial deviation includes placement 
of the fulcrum over the radiocarpal joint with the stationary arm bisecting 
the forearm and the moveable arm following the 3rd metacarpal. See 
Figures 3 and 4. 
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Figure 3. Goniometric Placement for Ulnar Deviation. 
Figure 4. Goniometric Placement for Radial Deviation. 
• Goniometric placement for the 1 SI digit IP flexion includes the fulcrum 
placed over the IP joint and the stationary and moveable arms parallel to 
the middle and distal phalanges respectively. See Figure 5. 
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Figure 5. Goniometric Placement for 1st Digit IP Flexion. 
• Goniometric placement for the 1 st digit Mep flexion includes the fulcrum 
placed over the Mep joint and the stationary and moveable arms resting 
over the proximal and middle phalanges, respectively. 
Figure 6. Goniometric Placement for 1 st Digit Mep Flexion. 
• Goniometric placement for flexion of the 2nd_5th Mep joints includes the 
fulcrum over the Mep joint and the stationary and moveable arms resting 
on the proximal and middle phalanges, respectively. See Figure 7. 
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Figure 7. Goniometric Placement for Mep Flexion. 
• Goniometric placement for flexion of the 2nd_5th PIP joints includes the 
fulcrum placed over the PIP joint with the stationary and moveable arms 
resting on the proximal and middle phalanges, respectively. See Figure 8. 
Figure 8. Goniometric Placement for PIP Flexion. 
• Goniometric placement for flexion ofthe 2nd_5th DIP joints includes the 
fulcrum over the DIP joint and the stationary and moveable arms resting 
on the middle and distal phalanges, respectively. See Figure 9. 
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Figure 9. Goniometric Placement for DIP Flexion. 
• Goniometric placement for extension ofthe 15t_5 th Mep, PIP, and DIP 
joints includes the fulcrum over the respective joint, the stationary arm 
over the more proximal phalanx, and the moveable arm over the more 
distal phalanx. 
Figure 10. Goniometric Placement for Extension of the 2nd _5 th Digits. 
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Poly-Arthritis Assessment 
A Poly-Arthritis Assessment Form used in this study is located in Appendix E. 
This form included subjective and objective information regarding duration of morning 
stiffness (measured in hours), number of active joints, current joint pain, and fibromyalgic 
point totals. 
The number of active joints was assessed by palpating the following joints 
bilaterally: The 1st_5th MCP, 1st IP, 2nd_5th PIPs and DIPs, radiocarpal, humeroulnar, 
glenohumeral, and sternoclavicular joints. They were rated subjectively by the patient in 
terms of pain and objectively by the tester in terms of bogginess. Pain was rated as 
minimal, moderate, and severe. Bogginess was measured in terms of present or absent. 
Even if the joint was subjectively sore, bogginess was the determining factor in labeling 
the joint as active. 
Current joint pain was assessed using a visual analog scale rating pain from 0 to 
10 (0 equaling no pain and 10 equaling worst possible pain). If the pain was rated 
between two numbers, it was recorded as "X.50". For example, if the subject reported 
her pain in between the numbers of five and six, 5.5 was recorded. 
Fibromyalgic points were assessed in nine sites on the body, bilaterally. These 
included occipital, trapezius, supraspinatus, low neck, second rib, inner knee, outer 
elbow, gluteus, and trochanteric sites. 
• The occipital point is located at the subocciptal muscle insertions.5 
• The trapezius point is located in the midpoint of the upper trapezius musculature. 
• The supraspinatus fibromyalgic point is located just superior to the scapular spine 
near the medial border. 
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• The gluteus fibromyalgic point is located in the upper outer quadrant of the gluteal 
muscle, in the anterior fold ofthe musculature. 
Figure 11. The Posterior Fibromyalgic Points Assessed. 
• Deferring from the American College of Rheumatology defined points, the low 
neck fibromyalgic point4 is located in the 2nd intercostals space, just lateral to the 
costochondral junction, approximately one finger breadth. 
• Also deferring from the American College of Rheumatology, the second rib point 
is located in the origin of the pectoralis major muscle, below the second rib in the 
intercostals space, near the costochondral junction. 
• The fibromyalgic point tested at the outer elbow is located just distal to the lateral 
epicondyle by two centimeters.5 
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Figure 12. An Anterior View of the Upper Body Fibromyalgic Points Assessed. 
• The inner knee point is located at the medial fat pad proximal to the joint line. 
Figure 13 . The Inner Knee Fibromyalgic Points Assessed. 
• The trochanteric fibromyalgic point is located just posterior to the greater 
trochanter; it is found by having the patient internally and externally rotate the hip. 
• Note the elbow and gluteus fibromyalgic points are also displayed in the lateral 
VIew. 
21 
Figure 14. The Lateral Fibromyalgic Points Assessed. 
The patient was standing while the trochanter and gluteus fibromyalgic points 
were tested. All other points were assessed in the seated position. Approximately four 
kilograms of force was applied to the region in a circular fashion, covering a one-
centimeter diameter. The patient rated the pain using a 0-2 scale; zero being no pain, one 
rating mild pain, and two equaling severe.4 
Intra-rater Reliability and Inter-rater Reliability 
Intra-rater reliability and inter-rater reliability was established for both testers 
prior to initiation of the testing procedures. Each tester measured nine subjects, using the 
average of three measurements. Measurements were recorded by an observer and were 
taken on two separate occasions, with a three-day span, to decrease the chance of rater 
biased or memory recall. 
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Joints Rater One Rater Two 
1 ST DIGIT-IP FLEXION 0.9710 0.978 
1ST DIGIT-IP EXTENSION 0.9741 0.971 
ND DIGIT-MCP FLEXION 0.9044 0.979 
ND DIGIT-MCP EXTENSION 0.9880 0.996 
RD DIGIT-PIP FLEXION 0.9024 
RD DIGIT-PIP EXTENSION 0.9295 0.982 
TH DIGIT-DIP FLEXION 0.9767 
TH DIGIT-DIP EXTENSION 0.9899 0.9231 
RIST FLEXION 0.9524 0.962 
RIST EXTENSION 0.9489 
OT AL DEVIATION 0.9011 0.9592 
Table 1. Intra-Rater Reliability of Raters 
Inter-rater reliability was established by having both raters measure the joints 
listed in the table below on nine subjects, using an average of two measurements for their 
final measurement. As with all measurements throughout this case report, if the average 
of two measurements fell between the two, the next highest whole number was used. The 
following is a table showing the inter-rater reliability using an Intraclass Correlation 
Coefficient (ICC). Literature states there is a substantial agreement of reliability if the 
average measure of ICC is equal to or greater than 0.90.24 All of the following, except 
total deviation, met this requirement. Total deviation's ICC measure was 0.88 which, 
literature states is a high reliability. 




1st Digit DIP Flexion 
2nd Digit PIP Flexion 
3rd Digit DIP Flexion 









Table 2. Inter-Rater Reliability Between Raters 
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Data Analysis 
Data was analyzed using the 10.0 version of SPSS statistical software for inter-
rater and intra-rater reliability. All other data analysis was computed at the United States 
Department of Agriculture's Human Nutrition and Research Center in Grand Forks, 
North Dakota by a research analyst using the statistical program SAS, Version 8.02. 
Reporting of Results 
Upon completion of the study, a summary of the results will be completed and 
sent to Dr. Curtiss Hunt, M.D. at the United States Department of Agriculture's Human 
Nutrition and Research Center in Grand Forks, North Dakota. Copies of this case report 
will be given to both the preceptor, Beverly J. Johnson, PT, MS, and the University of 
North Dakota Health Sciences Library. This study was completed to partially fulfill the 
requirements for the University of North Dakota School of Medicine and Health Sciences 
Master of Physical Therapy Program. 
Chapter IV 
RESULTS 
The data for this study was collected from the weekly range of motion 
measurements, Poly-Arthritis Assessment form, and self-assessment forms. The United 
States Department of Agriculture Human Nutrition and Research Center, Grand Forks, 
North Dakota provided data analysis for the case report. Limitations of analyzing the 
results must be noted because only one individual's records were used and this cannot be 
generalized towards the population of individuals with rheumatoid arthritis. Prior to the 
study, Dr. Curtiss Hunt, calculated a need for data from 14 individuals in order to 
establish a power of significance. See Appendix C. 
Subject Profile 
One female subject, age 49, participated in the study. She habitated at the Human 
Nutrition and Research Center in Grand Forks, North Dakota for the duration of the 
study. During this time, boron supplementation or deprivation was regulated by her daily 
food intake. Concurring with this alteration of her daily boron intake, the assessment of 
her joints was taken weekly. These assessments included range of motion of all 
dexterity-related joints of the hand and wrist, pain assessment, count of active 
fibromyalgic points, and active joint assessment. The subject was diagnosed with 




Is the range of motion affected in dexterity-related joints through the 
administration of boron? Is there a significant reduction of the bagginess and/or 
sensitivity of the dexterity-related joints when a specified level of boron supplement is 
governed? Does the number of active fibromyalgic points chosen from the assessment 
form significantly alter when boron is administered in a specified dosage? What impact 
do the physical and psychological aspects have on the physical therapy treatment of these 
individuals? 
Range of Motion 
Range of motion was determined by using a two-point regression analysis. Those 
joints that demonstrated a p < 0.05 for boron supplementation, deprivation, or both are 
included in Table 3. 
Soreness 
Presented below is soreness as documented during the weekly Poly-Arthritis 
Assessment. The table shows the percentage of time the subject presented with soreness 
on boron supplementation compared to when the subject was deprived of boron. Joints 
that showed a difference of more than 25 percentage points are noted in Table 4. 
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~oint I Boron Supplementation I Boron Deprivation 
Right 3rd Mep Flexion X 
Right 5th PIP Flexion X 
Left 5th PIP Flexion X 
Right Wrist Extension X 
Left 2nd Mep Extension X 
Right 2nd PIP Extension X 
Right Thumb Mep Flexion X X 
Left Thumb IP Extension X X 
Right 2nd Mep Extension X X 
Right 2nd PIP Flexion X X 
Left 2nd PIP Extension X X 
Right 2nd DIP Extension X X 
Left 3rd DIP Extension X X 
Right 4th Mep Extension X X 
Left 4th Mep Flexion X X 
Right 5th Mep Flexion X X 
Left 5th Mep Flexion X X 
Left 5th PIP Flexion X X 
Right Wrist Flexion X X 
Right Total Wrist Deviation X X 
Left Total Wrist Deviation X X 
Table 3. Range of Motion Measurement Changes (p < 0.05) 
Poly-Arthritis Assessment % of Soreness % of Soreness 
With High Boron with Low Boron 
Left 3rd Mep 100.00 63.63 
Left 2nd Mep 0.00 54.54 
Right Glenohumeral 27.27 0.00 
Right Radiocarpal 45.45 18.1€ 
Right 3rd Mep 81.81 27.27 
Right 2nd Mep 18.18 54.54 
Right 1 st Mep 9.09 45.45 
Table 4. Soreness Present as Measured by the Poly-Arthritis Assessment Form 
Bogginess 
The Table 5 reports the resulting percentages that bogginess was noted by the rater 
during the weekly assessment. 
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Poly-Arthritis Assessment % of Bogginess % of Bogginess 
With High Boron with Low Boron 
Left 2nd MCP 0.00 36.36 
Right 2nd MCP 18.18 72.72 
Right 1 st MCP 100.00 54.54 
Table 5. Bogginess Present as Measured by the Poly-Arthritis Assessment Form 
Presence of Swollen Joints During Self-Assessment 
The following table describes the frequency of swollen joints that were noted by 
the subject during her self-assessment. Only the joints displaying a difference of 15 
points or greater are noted in the chart below. 
Self-Assessed Joint High Boron Low Boron 
Yes I No Yes I No 
R radiocarpal 29 48 59 17 
R 5th MCP 50 27 68 8 
R 5th DIP 48 29 74 2 
R 4th MCP 58 19 73 3 
R 4th PIP 60 17 75 1 
R4th DIP 65 12 76 a 
R 3rd MCP 13 64 52 24 
R 2nd MCP 42 35 24 52 
R 2nd PIP 40 37 58 18 
RCMC 9 68 58 18 
R 1st MCP 1 76 31 45 
R 1st IP 3 74 60 16 
L radiocarpal 38 39 60 16 
L 5th MCP 40 37 71 5 
L 5th PIP 30 47 71 5 
L 4th MCP 64 13 76 0 
L 3rd MCP 25 52 54 22 
L 2nd PIP 46 31 61 15 
L 2nd DIP 50 27 69 7 
LCMC 13 64 58 18 
Table 6. Self-Assessment of Swollen Joints 
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Presence of Painful Joints During Self-Assessment 
The table below indicates the joints shown to have a difference of 15 points or 
more in frequency from the subject's self-assessment data of painful joints. 
Self-Assessed Joint High Boron Low Boron 
Yes I No Yes I No 
R radiocarpal 5 72 57 19 
R 5th MCP 20 57 70 6 
R 5th PIP 26 51 70 6 
R 5th DIP 48 29 74 2 
R 4th MCP 60 17 73 3 
R 4th PIP 59 18 75 1 
R4th DIP 65 12 76 0 
R 3rd MCP 19 58 52 24 
R 2nd MCP 43 34 25 51 
R 2nd PIP 40 37 58 18 
RCMC 8 69 58 18 
R 1st MCP 2 75 35 41 
R 1st IP 4 73 60 16 
L radiocarpal 4 73 50 26 
L 5th MCP 40 37 71 ~ 
L 5th PIP 34 43 71 ~ 
L 5th DIP 47 30 74 2 
L 3rd MCP 31 46 54 22 
L 2nd DIP 50 27 69 7 
LCMC 7 70 58 18 
Table 7. Self-Assessment of Painful Joints 
Morning stiffness, while on boron supplementation, had a calculated mean of 
0.909 hours, with a standard deviation of 1.375 as compared to 0.318 hours, with a 
standard deviation of 0.751, while deprived of boron. Pain averaged 4.273 on a 0-10 
scale while on boron supplementation, with a standard deviation of 1.272. Pain averaged 
only 2.272 on a 0-10 scale while deprived of boron, with a standard deviation of 1.348. 
The total number of active joints was determined each week, presiding on the presence of 
29 
bogginess and soreness. This was calculated to have a mean of 5.364 joints while on 
supplementation of boron, as compared to 4.909 joints with deprivation of boron, with 
standard deviations of 2.767 and 2.844, respectively. Fibromyalgic points had a 
maximum of 36 points for the total count and the patient objectively presented with a 
mean of 15.182 while on boron supplementation, as compared to 9.909 while deprived of 
boron, with standard deviations of 4.665 and 3.833, respectively. 
By analyzing the above information, it is apparent that boron supplementation 
resulted in a general overall decrease in the subject's average hours of morning stiffness, 
fibromyalgic tender points, and subjective pain; however, the active joints remained 
relati vely consistent. 
Chapter V 
DISCUSSION 
Rheumatoid arthritis is due to a systemic, inflammatory process chronically 
occurring within the human body. Joint and tendon destruction may be a debilitating 
result. Research has documented that boron supplementation has increased the range of 
motion of the joints in laboratory rats and delayed the onset of rheumatoid arthritis in 
rats.6, 7, 25 Pertaining to the former study, signs of inflammation and swelling were 
evident in the contralateral paw to a much greater degree with a boron low diet.25 This 
suggests that ample amounts of boron may decrease the inflammation in joints of 
laboratory rats. No previous studies have documented these effects in human subjects at 
this time. The results of this case report were not consistent with those presented in the 
animal study. 
Subjective pain, hours of morning stiffness, and fibromyalgic tender points 
decreased with the subject during high boron intake, however, range of motion was 
affected in roughly one-third of all motions tested in the dexterity-related joints. It is 
pertinent, to this scholarly project, that one does not generalize the effects of boron 
supplementation in dexterity-related joints to all individuals with rheumatoid arthritis. 
The information presented here is a case report for one subject only. No conclusive 




The results of this case report have shown that the number of active joints for our 
subject remained relatively constant. This demonstrates that the bogginess and 
soreness/sensitivity to palpation were still present. However, interestingly, the subjective 
rating of pain, fibromyalgic points, and hours of morning stiffness decreased with boron 
deprivation. 
By analyzing the range of motion statistics, it was found that 21 motions out of 
the possible 64 motions tested displayed changes. These generally displayed slopes in a 
two-point regression analysis indicating an increase in the range of motion with boron 
supplementation and a decrease in the range of motion with boron deprivation in the 
measurements of dexterity-related joints for this subject with rheumatoid arthritis. 
Limitations of Study 
The first limiting factor of this study was the sample size of one. With only one 
subject used in this data analysis, generalization cannot occur. No conclusive evidence 
could be made due to the randomized effects with boron supplementation and 
deprivation. 
Two raters were involved in the weekly assessments for this case report; however, 
further research may attempt to use only one rater. Literature supports intra-rater 
reliability as being higher than inter-rater reliability?3 
As rheumatoid arthritis and fibromyalgia are commonly inter-correlated, the 
tender points are a powerful discriminator against patients with rheumatoid arthritis and 
controls.5 For future studies, to increase the reliability and validity of assessing 
fibromyalgia points, raters should determine inter and intra-rater reliability to ensure the 
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use of approximately four kilograms of force using the pulp of the thumb or the first two 
or three digits. 
Humans are highly complex individuals, and difficulty arises when attempting to 
compare human subjects with animal subjects. Even though a controlled environment 
existed, we are not able to control all factors. 
The study was conducted in a region where seasonal changes occur. The study 
encompassed seasons from mid-winter through spring and into early summer. This may 
influence the joint inflammatory process. It is documented that persons with rheumatoid 
arthritis may have a high sensitivity to weather patterns, however one study indicated that 
this may not be clinically significant.26 Individuals with fibromyalgic symptoms have 
reported aggravation due to environmental stress factors. 27, 28 
Research supports that some psychological factors have an influence on the 
immune system29 and, therefore, are an integral part of living with rheumatoid arthritis. 
Also, physical and emotional stress factors have proven to aggravate symptoms in 
individuals with fibromyalgia,z7, 28 Further research may attempt to look more in-depth to 
the components of psychological self-assessment. During our data analysis of this study, 
we did not address the impact of psychological issues. The ability to cope with pain30, 31 
and mood may all impact the subject's perception of pain and therefore, alter objective 
values of a study. 
Physical Therapy Application 
The above data represents the vast factors associated with rheumatoid arthritis and 
the impact it can have on the physical being of an individual. Physical therapists must 
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realize that psychological issues can result as the patient attempts to deal with the daily 
physical limitations of the disease. Physical therapy goals will focus on reducing pain, 
controlling inflammation, maintaining mobility, and minimizing stiffness, edema, and 
joint destruction.3 Physical therapy treatment for rheumatoid arthritis may include, but 
are not limited to the following: strengthening, stretching to improve or maintain range 
of motion, splinting to prevent deformity, biofeedback, TENS (transcutaneous electrical 
nerve stimulation), aerobic components, aquatic therapy, and gait analysis. 
Strengthening is a large component of physical therapy. It is important to 
strengthen not only the hands or involved joints of an individual with rheumatoid 
arthritis, but it is also necessary to strengthen the other joints that may not yet be 
involved.32 Fernandez-Madrid32 states, "For example, some patients in whom the hands 
and other joints of the upper extremities are predominantly involved may not understand 
why they should exercise their legs." During exercise, the use of the legs helps with the 
efficiency of blood return to the heart and surrounding muscles. 
Stretching exercises will most likely relieve the muscle tightness caused by either 
disuse or inactivity.32 One of the main purposes of stretching is to prevent contractures or 
to increase the range of motion after a contracture has occurred in individuals with 
rheumatoid arthritis. In progressive stages of rheumatoid arthritis, splinting can be a 
method of stretching scar tissue formed in the joint by providing a prolonged and gentle 
force to a specific joint or joints. Splinting can also be used during the inflammatory 
stage to rest the joints and maintain balance of the agonist and antagonist muscles. 
It is important to realize that both strengthening and stretching should be 
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performed after the duration of morning stiffness has subsided, with the exception of the 
individual who's stiffness lasts all day.32 In the latter case, strengthening and stretching 
should not be performed when active joint involvement occurs, manifested by the 
evidence of inflammation and pain. 
Electrical current therapies are a component often used in the realm of physical 
therapy treatments. Biofeedback has been reported to reduce the pain in individuals with 
rheumatoid arthritis.33 TENS (transcutaneous electrical nerve stimulation) has been 
proven to reduce the painful symptoms associated with rheumatoid arthritis in 18 out of 
20 individuals at the frequency of 70 hertz.34 
Dynamic exercise improves joint mobility, muscle strength, aerobic capacity and 
daily functioning in individuals with rheumatoid arthritis. 16 Evidence in several studies 
does not support an adverse effect of exercise on joint integrity, or an increase in the 
inflammation of the joints. 16, 35 
Due to the fact that swimming is a non-weight-bearing activity, it is ideal and 
beneficial for patients with rheumatoid arthritis because of the involvement of the joints 
in all extremities.32 Aquatic therapy is a non-impact activity and, therefore, results in a 
decreased amount of stress on the individual's joints. 
When evaluating gait, dynamic exercises such as walking or jogging promote 
cardiovascular fitness, however, these exercises may not be possible or may even be 
contraindicated, depending on the individual's involvement.32 
Due to the chronicity of the disease process, patient education and establishing 
patient compliance to therapeutic treatment are essential to obtain maximal benefits. The 
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therapist must provide a balance between rest and activity to ensure that overexertion 
does not exacerbate the symptoms, but that the patient remains active enough to prevent 
deformity. Reducing the inflammatory process will allow the patient to be active and to 
decrease the likelihood of future joint destruction, especially in dexterity-related joints of 
the hand and wrist.4 
Several items have been proposed and experimental in the hunt for a cure of 
rheumatoid arthritis. At best, palliative care has focused on a number of aspects 
including Cox-2 Inhibitors, massage, acupuncture, herbal remedies, and anti-
inflammatories. One must realize as a physical therapist treating individuals with 
rheumatoid arthritis, that a multi-dimensional and holistic approach must be taken. As 
therapists, we can assure optimal treatment for our patients if we remain current on 
updated technology, treatment techniques, and potential cures for rheumatoid arthritis. 
This case report must be interpreted with caution, due to the limitations of this 
study. Future research should address a sample size large enough to meet a statistical 
power that can be generalized to the population. As a sample size with statistical power 
would allow data analysis to determine a significant difference in collected data for boron 
deprivation and supplementation periods. 
It is valuable to the integrity of the healthcare system and medical field as a 
whole, that further research be conducted on treatments for rheumatoid arthritis. The 
valuable information provided by research, combined with the physical therapy 
components, and patient relations with proper communication will allow for effective 
treatment of individuals with rheumatoid arthritis. Literature demonstrates aspects of 
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communication are positively correlated with patient satisfaction36, adherence to 
treatments3?, and general health status38. As healthcare providers, it is vital to listen to 
your patient, understand what he or she is saying both verbally and nonverbally, and 
combine all aspects of treatment and research with sincere care for your patients. 
"People don't care what you know, until they know that you care." -Author Unknown 
APPENDIX A 
DEFINITIONS 
1. Rheumatoid arthritis: is a progressive and systemic disease marked by 
inflammation, which leads to deterioration of the joints. Fibrosis of the synovium often 
results, causing a decrease in range of motion, stiffness, swelling, and possible deformity 
of the affected joints. 39 
2. Bogginess: is a physical characteristic used to describe excessive fluid found 
in affected joints. 
3. Fibromyalgia: is chronic and frequently difficult to manage pain in muscles 
and soft tissues surrounding joints that can be associated with rheumatoid arthritis.39 
4. Fibromyalgic tender points: characteristic "active" sites that are tender and can 
be distinguished from equally characteristic "control" points that are non-tender.4 
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affects immune function; boron deprivation increased the severity and incidence of experimental rheumatoid arthritis, an 
inflammatory disease. Findings from these animal experiments support the hypothesis that physiologic amounts of dietary 
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typically elevated during the normal inflammatory process such that boron permits elimination of pathogens but avoids 
autoimmunity. Previous studies in humans indicate that physiologic amounts of dietary boron improve mental function and 
vitamin D status but none have examined the physiologic role of boron on inflammatory disease. Although the findings with 
boron deficient animals are convincing, only controlled studies with human volunteers fed diets containing low (but common 
today) boron will establish whether such diets have important consequences for health in the general population. 
42 
Physiologic Amounts of Dietary Boron as a Factor in the Manifestation of Rheumatoid Arthritis 
PLEASE NOTE: Only infomJation pertinent to your request to utilize human subjects in your project or activity should be included on this fonn. Where appropriate, 
attach sections from your proposal (if seeking outside funding). . 
2. PROTOCOL: (Describe procedurcs to which humans will be subjected. Use additional pages if necessary. Attach any surveys, tests, questionnaires, interview 
questions, examples of interview questions [if qualitative research], etc. the subjects will be askcd to complete.) 
Rationale and Objective: Several attempts have been made, including at the Grand Forks Human Nutrition Research 
Center, to establish that a dietary deprivation of boron results in changes in biochemical and physiological indices that could 
lead to pathological consequences. These studies have been particularly successful and most studies used animal models 
under nutritional stress including vitamin D, magnesium, or calcium deficiency. Variables typically examined here and at 
other independent laboratories were those related to bone and cartilage structure and function, energy substrate and mineral 
metabolism, immune function and embryological development. It is now well established that physiologic amounts of dietary 
boron help protect against moderate vitamin D deficiency (manifested as rickets) in animal models, that dietary boron 
improves circulating concentrations of vitamin D metabolites in humans and animals, and that boron is needed for normal 
embryological gastrulation of frog and fish species. There is further evidence from the fetal rat model that boron is important 
in vertebral column development. The exact molecular mechanism responsible for these effects has not been determined. 
However, in vitro interactions between boron and several boron-binding biomolecules are well characterized; boron is a 
reversible inhibitor of all examined serine protease and NAD+ -, NADP, and FAD-requiring oxidoreductase enzymes. Several 
of these enzymes are integral components of the neutrophil respiratory burst process, the blood coagulation cascade, or the 
complement and leukotriene biochemical pathways. These metabolic pathways are, in turn, major components ofthe normal 
inflammatory process, the physiological mechanism that normally eliminates antigens without evidence of clinically 
detectable inflammation. 
Excessive inflammation leads to inflammatory disease. Findings from elsewhere indicate that rheumatoid factor is rapidly 
and completely precipitated in boric acid solutions (2%) in vitro and prompted the hypothesis that boron reacts with sugar 
moieties in the rheumatoid factor to form a reversible complex. Research in this laboratory on the possible relation between 
dietary boron and inflammatory disease was based on knowledge of the reversible nature of boron enzymatic inhibition and 
appreciation of rheumatoid arthritis as an inflammatory, autoimmune disease of unknown etiology. We demonstrated that 
physiologic amounts of dietary boron reduced paw swelling and increased circulating concentrations of natural killer cells 
in rats with antigen-induced rheumatoid arthritis. Thus, published research fmdings to present indicate beneficial 
immunomodulatory effects for dietary boron possibly brought about by the suppression, but not elimination, of the activity 
of enzymes involved in the normal inflammatory process. The proposed research will establish whether physiological 
amounts of dietary boron affect clinical manifestations of human rheumatoid arthritis, a chronic intlammatory disease more 
prevalent In single or divorced women compared to man'ied women, and associated with lower income and lower educational 
levels . A study showed that the value of expected lifetime costs of rheumatoid arthritis, on a per capita basis, amounted to 
$20,412 (1977 dollars). Careful assessment of mineral balance of volunteers with rheumatoid arthritis will substantially 
improve our ability to provide nutritional counseling to patients with rheumatoid arthritis. 
Sample Size: A statistical power analysis was conducted to determine the number of subjects needed to achieve 90% power 
to detect significant (0.= 0.05) treatment effects. Data from previous studies that had manipulated drug treatments for control 
of RA were used to estimate effect sizes and variance components. Based on the analysis of prior CD8+CD25+ lymphocyte 
concentrations, 14 subjects are needed to achieve 95% power. An analysis oftender or swollenjoints indicated that 8 subjects 
are needed to achieve 99% power. 
Participants: Fourteen, non-smoking (tobacco or medicinal marijuana), non-alcoholic women (with target of 60-65 years 
of age), with physician-diagnosed chronic rheumatoid arthritis (RA) (as described below), will be recruited by and Internet 
website (programmed so that the key words rheumatoid arthritis, bones, and boron will be found by search engines) or 
magazine or television advertisement throughout the United States. Letters soliciting referrals will be sent to physicians. The 
letter will explain the study and request that the physicians distribute the enclosed brochure to their patients. Patients who 
wish to participate can then call the HNRC toll free, write to HNRC, or contact them bye-mail. If direct solicitation to 
physicians is not productive, a letter with the same enclosed brochure will be sent to local chapters of the Arthritis foundation. 
Subjects selected to enter the study wil) be informed in detail of the nature of the research, including the risks and benefits. 
Subjects may exhibit physical symptoms ofRA in other than in the upper limbs or in extra-articular regions (within limits 
defined below) but must be fully ambulatory and able to carry out non-assisted bodily toilet, showering, and washing 
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functions (with modified toilet, shower, and sinks controls), collection (as described below) of all urine and fecal materials 
(with mechanical aids if needed), and consumption of all foods, beverages, nutrient supplements, and medications (with 
mechanical aids ifneeded). Candidates will be screened atno cost to them for medical, nutritional, and psychological health 
by telephone· interviews, written questionnaires, report of their personal physician after local visit, examination of complete 
medical records by a study physician, and onsite examination by clinical laboratory, psychology, dietary, and medical staff 
and consultants. Medical records are obtained by asking the volunteer· to fill out a release form to send to the clinic where 
their records are kept. Ineligible candidates and alternates will be notified by phone or mail. Alternates will be accepted if 
an original volunteer leaves or is dismissed from the study. women will be used because this faction of the population is 
most likely to have poor boron status and thus the findings can be directly related to this susceptible group. 
Medical selection criteria: 
A. Rheumatoid Arthritis (RA). At the time of selection, eligible candidates will manifest rheumatoid arthritis (RA) as 
defined by the American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis 
(Arthritis and Rheumatism, 31 :315-324, 1988). This is the presence of four or more of the following criteria: 
1) morning stiffness in and around joints lasting at least one hour before maximal improvement; 
2) at least three joint areas simultaneously have had soft tissue swelling or fluid (not bony overgrowth alone) 
observed by a physician. The 14 possible areas are right or left proximal interphalangeal, metacarpophalangeal, 
wrist, elbow, lmee, anlde, and metatarsaphalangealjoints; 
3) at least one area swollen (as defined above) in a wrist, metacarpophalangeal, or proximal interphalangeal joint; 
4) simultaneous involvement of the same joint areas (as defined in 2) on both sides of the body (bilateral 
involvement of proximal interphalangeals, metacarpophalangeals, and metatarsaphalangeals is acceptable 
without absolute symmetry); 
5) subcutaneous nodules, over bony prominences, or extensor surfaces, or in juxtaarticular regions, observed by 
a physician; 
6) demonstration of abnormal amounts of serum rheumatoid factor by any method for which the result has been 
positive in <5% of normal control subjects; and 
7) radiographic changes typical of rheumatoid arthritis on posteroanterior hand and wrist radiographs, which must 
include erosions or unequivocal bony decalcification localized in or most marked adjacent to the involved joints 
(osteoarthritis changes alone do not qualify). 
8) Criteria 1 through 4 must have been present for at least 6 weeks. 
B. Prior Manifestation of Rheum!ltoid ArtbIitic_lltat,<: To limit the need for significant volunteer care, health status 
monitoring, and modification of existing facilities, all ofthe following additional selection criteria must also be met 




RA status is stabilized as indicated in personal medical records; 
No manifestation, for at least 2 years immediately prior of any inflammatory disease, other than RA, or chronic 
disease unassociated with rheumatoid arthritis; 
Functional capacity is not Class 3: adequate to perform few or none of the duties of usual occupation or self-
care; 
4) Functional capacity is not Class 4: total or almost total incapacitation, with patient bedridden or confined to 
wheelchair, able to perform little or not self-care; 
5) None of the following systemic manifestations ofRA or adverse effects of drugs sometimes present in an advanced 
RA state are present: 
a) Severe vasculitis manifest as necrotizing arteritis of either small- or medium-sized vessels, erythema elevatum 
diutinum (very painful, indurated crusted lesions) gangrene, intestinal infarction, myocardial infarction, central 
nervous system vasculitis, or renal vasculitis. 
b) Felty's Syndrome (splenomegaly with neutropenia, hepatomegaly, lymphadenopathy, sinus infection, 
·pneumonia, highly expressed rheumatoid arthritis, leg ulcers). 
c~ Eye 
1. Focal, diffuse, or nodular scleritis (congestion and inflammation of the sclera; deep aching, increased 
tearing; thinning of sclera [scleromalacia]; melting cornea syndrome [keratolysis]; nodular lesions that 
erode the sclera, with perforation of underlying ocular material [scleromalacia peforans/perforation of the 
eye]). 
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2. Eye movement disorders (rheumatoid nodules in tendons of ocular muscles; local cranial nerve palsy from 
vasculitis; cortical blindness from vasculitis). 
3. Loss of epithelium over cornea in dry eye associated with Sjogren's syhdrome. 
d) Compression neuropathy to cause: 
1. Bladder dysfunction 
2. Headache 
3. Cervical spine subluxation. 
e) Heart 
1. No prior history of heart failure, or hypertension 
2. Constrictive pericarditis and cardiac tamponade. 
3. Arrythmias and conduction disturbances. 
4. Valvular abnormalities causing stenosis or insufficiency. 
f) Lung 
1. Caplan's syndrome (intrapulmonary nodules). 
2. Obstructive sleep apnea. 
3. Upper airway obstruction by cricoarytenoid arthritis. 
4. Pulmonary fibrosis. 
g) Gastrointestinal Tract/Liver 
1. Evidence of gastrointestinal ulcers or perforations as a result ofRA medication or any other cause, lactose 
intolerance, malabsorption, inflammatory infiltrates of lamina propria, bowel infarction, postprandial 
abdominal angina, amyloid involvement in the gut, hepatitis, cholestasis, vasculitis; 
Living Environment: The women will reside in the metabolic ward ofthe Grand Forks Human Nutrition Research Center. 
Each subject will be provided with a private bedroom with cable television, radio with wake-up alarm, intercom to 24-hour 
nurses station, and telephone, and a semi-private bathroom. Four separate lounges (for computer [with full Internet access], 
music, card game, big-screen TV, fireside, and other activities), one laundry room, one whirlpool bathroom, one craft room, 
one exercise (stationary bicycle) area, one ping-pong/active game area, one outdoor patio, one 24-hour nurses station, and 
one refreshment room (with refrigerator, sink, microwave) are adj acent to the private bedrooms. All meal consumption and 
several experimental assessments take place within the building on floors different than that ofthe main living suite that are 
accessible by either stair or an elevator. To avoid extraneous joint trauma and swelling, walking aids will not be provided 
except. for movement in private bedroom and shared bathroom. Rather, in the unexpected situation where a subject 
experiences an RA flare-up that degrades ambulatory status, a non-motorized wheelchair escorted by a staff member will be 
provided until adequate ambulatory status returns. The subjects will consume only and all foods, beverages, and vitamin. 
mineral, or other supplements provided by the Grand Forks Human Nu1:J.ition.Research Center and will be allowed to leave 
the immediate living or dining areas, or facility only when accompanied by a chaperone. Meal consumption is observed by 
specially trained dietary staff and irregularities are recorded. Subjects must agree to use only those personal care products 
and in the amounts approved by the principal investigator to limit and standardize extraneous chemical exposure. 
Rheumatoid Arthritis Therapies: Specific therapies for RA prescribed by a physician or subject-selected prior to the start 
ofthe study are incorporated into the study design to standardize treatment and to reduce possible masking ofthe effects of 
dietary boron. As such, the approved therapies are continuations of previous therapies, not new treatments. 
A. Methotrexate therapv forrheumatoid arthritis. Active low-dose (7-20 mg/week) methotrexate therapy forrheumatoid 
arthritis is a selection criterion. The use of oral methotrexate in a low dose given once weekly has become the 
mainstay of therapy for active and sustained rheumatoid arthritis. All subjects must certify that they have received 
methotrexate for rheumatoid arthritis and rheumatoid arthritis therapy only as prescribed by a physician. All subjects 
must certify that the methotrexate therapy has been stable for at least the last 6 months before the start of the study. 
All subjects must agree to continue their individual methotrexate therapy throughout the study and only in the same 
form, brand, and dosage as that last prescribed by their personal physician before entry into the study. 
B. Auxiliarv therapies for rheumatoid arthritis. Active auxiliary therapy for RA is not a selection criterion. However, 
four other specific auxiliary therapies for rheumatoid arthritis are permitted if they have been stable for at least 4 
months before the start of the study. All subjects must agree to continue any approved pre-entry auxiliary therapy 
throughout the study and only in the same form, brand, and dosage as that taken before entry into the study. Any 
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subject not on one or more approved auxiliary therapies at the beginning of the study must agree to not start a~y 
alL1:.iliary therapy during the study. The approved auxiliary therapies are: 
1. Oral Nonacetylatedsalicylates (e.g., choline magnesium trisalicylate, magnesium salicylate [e.g., Magsal], sodium 
salicylate [pabalate], salsalate or salicylsalicylic acid [e.g., Salflex, or Disalcid]. Acetvlated salicylates [e.g., 
aspirin, Anacin Analgesic, Bufferin, Bufferin Arthritis Strength Analgesic Tablets]) ARE NOT permitted. 
Exceptions will be made at the discretion of the principal investigator. 
2. Oral Acetaminophen (e.g. Extra-Strength Tylenol), 
3. Oral Prednisone or equivalent and/or, 
4. Oral Hormone Replacement Therapv. 
C. Other therapy/medication for rheumatoid arthritis or other disease. During the study, the subjects must not regularly 
use medication except methotrexate for RA and the specific .approved auxiliary therapies. Subjects must agree to 
complete avoidance of all other traditional therapies for RA and all nontraditional treatments for RA (including, but 
not limited to, acupuncture, massage, homeopathic medications, fish oil, dimethyl sulfoxide [DMSO], venom) during 
the study. 
D. Medication control. All approved therapy for RA or auxiliary RA therapy during the study will be supplied to the 
subjects at no cost to them. Subjects must agree that all storage, dispensing, and inventory tracking of all medications 
(prescribed and over-the-counter) are under the complete control of the staff nurses on duty in the metabolic ward and 
must agree to not keep any medication in their private possession. The frequency and dosage of any medication will 
be recorded. 
Boron Content in Diet: Women aged 60-65 years are estimated to consume 0.731 mg of boron per day on average. For 
all women age 19 years and older, those in the 5'h percentile are estimated to consume 0.35 mg boron per day; those in the 
95'h percentile, 1.95 mg boron per day. Upon entering the study, the women will be fed the basal diet containing 
approximately 2.0 mg per 2000 kcal for 14 days. For the second dietary period (77 days), one-half of the subjects will be 
maintained on this diet and the other half will be fed the basal, non supplemented diet so that it will supply approximately 
0.3 mg per 2000 kcal. For the third dietary period (77 days), those subjects previously maintained on the basal diet will 
switch to the diet supplemented with boron (2.0 mg per 2000 Iecal), and those subjects previously maintained on the basal 
diet with boron supplement will switch to the basal diet without boron supplement. 
. Experimental Diet: All subjects will be asked to not take dietary supplements for 30 days before study entry. Each subject 
will be asked to participate in the study for a total of 168 days. Body weight will be monitored but allowed to fluctuate 
because RA often causes muscle wasting. At weekly intervals, at the written request of the subject, and after subject 
consultation with the dietary staff, the number of calories in their diet maybe adjusted either upward or downward in 200 
calorie increments two weeks after the request is made. However, body weight loss will be limited to -2% of initial body 
weight and will be corrected with 200 calorie increment increases. Body weight gain is acceptable. 
Mixed Western diets will be used such that the energy from protein, carbohydrate, and fat and all known essential nutrients 
the diet are similar to that consumed by women as estimated by a national food intake survey (U.S. Department of Agriculture 
Agricultural Research Service. Data tables:food and nutrient intakes by individuals in the United States, by region, 1994-96. 
Table Set 13. Online. ARS Food Surveys Research Group. February 1999). The calculated nutrient content ofthe diet will 
be adjusted by dietary supplements, if necessary to meet estimated average intakes of all known essential nutrients (except 
boron). To compensate for iron loss by phlebotomy, iron will be supplemented to provide about 27 mg per day. To 
compensate for known antagonistic effects of methotrexate on folic acid, folic acid will be supplemented at 1 mg above usual 
intake. 
Cardiac Monitoring: Heart rhythm will be monitored by a 20-hour electrocardiogram obtained by ambulatory cardiography. 
These. will be obtained every two weeks. Twelve lead electrocardiograms may be done to check unusual results. 
Noninvasive RA Feature Assessment: To monitor and safeguard the health of the volunteer, physical assessments are 
conducted at three levels (volunteer, staff, and physician). All types of physical health assessment will be considered 
experimental variables. With written express permission of the volunteer, a copy or summary of the RA feature assessment 
findings will be sent directly to the volunteer's personal physician. To limit experimental bias, none of the members of the 
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research team, nursing staff, dietary staff, consulting or collaborating physicians, or any other staff at the Center, except for 
study physicians assigned to conduct physical examinations, are allowed to discuss, consul, or dispense advice concerning 
any medical treatment or medication related to RA. The same personnel are blinded to the dietary treatment. 
A. Joint Function Assessment: 
I. Daily: Self-reported checklist summaries morning stiffness and joint count. Staff assessment of swelling of 
proximal interphalangeal (pIP), metacarpophalangeal (NICP), and wrist joints, and subcutaneous nodules. 
2. Weeklv: Staff assessment of all limb, jaw, and clavicular joints identified on the standard Polyarthritis Assessment 
Form for ,swelling, damage, synovial effusion, tenderriess, or stress pain; wrist, hand, finger joint range of motion 
by goniometry; hand and wrist volume by water displacement. 
3, Biweekly: Staff assessment of grip strength, 
4. Week 2 of first dietary period. weeks 6 and 11 of second and third dietary period: Staff assessment of manual 
dexterity by using the Purdue Pegboard procedure. 
B. Extra-articular/Systemic RA Feature Assessment: 
1. Daily: Self-reported checklist summaries of indications of night pain, fever sweats, malaise or weakness, dry eyes, 
dry mouth. Staff assessment of (but unlikely presence of) nailfold infarcts, epidennal ulcers, inflamed eyes, 
pleural pain, tenderness in spine between C7 and L4, Raynaud's phenomenon (spasm ofthe digital arteries with 
blanching and numbness of fingers), Sjoegren's syndrome (dryness of mucous membranes and telangiectasias 
[dilation ofterminal capillaries] or purpuric spots on the face). 
2. Week 2 of first dietary period. weeks 6 and 11 of second and third dietary period: Study physician assessment of 
rheumatoid arthritic state by physical examination including monitoring for lymph node enlargement as a sign 
of methotrexate toxicity, Staff assessment ofhand tremor by using a standard steadiness test procedure (ability 
to hold a stylus inside a series of holes of decreasing diameter without touching the sides of the hole). 
Resting Energy Expenditure (REE): Weeldv for first 3 weeks. then monthly thereafter: REE is elevated in RA and will 
be measured by indirect calorimetry which is a measure of the oxygen consumed and the carbon dioxide given out. The rate " 
of O2 consumption underresting'conctrtions will be determined after a 12 hour fast. A face mask, similar to an oxygen face 
mask, will be used to collect respiratory gases after a 12 hour fast. Respiratory gases will be measured while the participants 
rest in a reclining position in a thermoneutral (room temperature) environment. At least 30 minutes will be allowed for 
stabilization ofthe respiratory gas measurements. Determination of O2 consumption and CO2 production will then be made 
for 15 minutes. 
Venipuncture: All blood will be drawn after an overnight fast (usually 12 hours). Phlebotomy will be perfonned by medical 
technicians or registered nurses. Techniques will be those used in standard hospital and clinic settings. As summarized 
below, blood for health status indicators (maximum of 13 rnL per phlebotomy) will be obtained during week two of the first 
dietary period, weeks 2, 4, 6, 8, 10, and 11 of the second dietary period, and weeks 2, 4, 6, 8, 10, and II of the third dietary 
period. Additional blood (maximum of 112 rnL additional) for rheumatoid arthritis, inflammatory response, oxidative 
response and boron deficiency indicators will be obtained during week two of the first dietary period, weeks 6 and II of the 
second dietary period, and weeks 6 and 11 of the third dietary period. As described below (see Boron Metabolism 
Assessment by Stable Isotope Enrichment), additional blood will be drawn during week 8 of the second and third dietary 
periods (maximum of24 mL each time). A ma.-umum of287 mL will be drawn in 8 weeks. The blood bank guidelines for 
blood donation volume and frequency is 475 ml every 8 weeks. The total maximum amount of blood drawn for the study 
is 712 mL. 
Tests done with blood will emphasize variables that will determine whether boron supplementation affects inflammatory 
function, oxidative metabolism, and mineral metabolism. Tests will also be done to establish and monitor health status. 
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A. Rheumatoid Arthritis Indicators:RBC sedimentation rate, rheumatoid factor, leukocyte phospholipase A2, serum type 
II collagen, antibodies to type II collagen, plasma fatty acid profile, plasma pyridoxal-5' -phosphate, and zinc. 
B. Inflammatory Response Indicators: leukocyte subset populations, serum TNF-alpha, IL-l; IL-2, IL-6, granulocyte-
macrophage colony stimulating factor (GM-CSF), insulin-like growth factor 1 (IGF-I), IFN-gamma, leukocyte ThlF-
alpha, dopamine, IL-8, and alpha-2 macroglobulin, C-reactive protein; leukocyte IL-I, IL-2, IL-6, granulocyte-
macrophage colony stimulating factor (GM-CSF), IFN-gamma, phospholipase ~; platelet phospholipase A2• 
C. Oxidative Metabolism Indicators: leukocyte oxidative burst, erythrocyte copper-zinc superoxide dismutase, 
extracellular superoxide dismutase, leukocyte manganese superoxide dismutase, plasma ascorbic acid, glutathione, 
homocysteine, vitamin E, and erythrocyte protein carbonyl formation. 
D. Boron Deficiencv Indicators: The following variables responded in previous human or animal model boron 
deprivation studies: protime/PIT, serum urea nitrogen, serum 25-hydroxyvitamin D3, osteocalcin, glucose, 
triglycerides, insulin, ionized calcium, calcitonin, 17 beta-estradiol, testosterone, bone specific alkaline phosphatase, 
plasma and whole blood boron, magnesium, calcium, copper, and molybdenum. 
E. Bone Metabolism Indicators: PTH, IGF-I, IGF-IBP-I , IGF-IBP-3, IGF-IBP-4, Ionized Mg, and 
Under-carboxylatedosteocalcin. 
F. Health Status Indicators: Erythrocyte sedimentation rate, complete blood count, folate, hemoglobin, hematocrit, 
ionized calcium, aspartate aminotransferase, alkaline phosphatase, albumin, serum phosphorus, iron, ferritin, total 
protein, creatine kinase, sodium, potassium, creatinine, total cholesterol. 
Boron Metabolism Assessment bv Stable Isotope Enrichment: Boron absorption and subsequent metabolism will be 
measured by using stable isotope enrichment technology. The typical natural ratio of the two stable (non-radioactive) 
isotopes of boron (B-1 0 and B-11) in foods is approximately 20:80 respectively. Volunteers will be provided a dose of B-1 0 
that was incorporated naturally by hydroponically-grown broccoli plants. These B-1 0 enriched plants are harvested, freeze-
dried, then fed to the volunteers during week 8 of the second and third dietary periods. An indwelling catheter is inserted 
into an arm vein for four hours to allow collection of 4 mL blood samples at 0,0.5, 1, 2,3, and 4 hours after the broccoli test 
meal is fed. Urine samples are collected at 0, 0.5, 1,2,3,4,5,6,7,8, 12, and 24 hours, and days 2-10 after the test meal is 
fed. Daily fecal samples are collected between 0 and 10 days after the test meal is fed. Blood, urine and fecal samples are 
analyzed by mass spectroscopy to track the transient changes in the natural B-1 0:B-11 ratio that will occur after consumption 
of the B-IO enriched broccoli thus allowing calculations of boron absorption and metabolism. 
Urine and Fecal Collection: Volunteers will collect all feces and urine so that the following tests can be done: 
A. Urine: Leukotriene -panel, hydroxyproline, N-teleopeptide, urea, uric acid, creatinine, oxalate, nitrate+nitrite, 
aluminum, boron, calcium, copper, iron, magnesium, manganese, molybdenum, phosphorus, potassium, sodium, 
nitrogen, and zinc and urinary cAMP (nephrogenous aAlVIP). 
B. Feces: aluminum, -boron, calcium, copper, iron, magnesium, manganese, molybdenum, phosphorus, potassium, 
sodium, zinc to allow determination of balance of these minerals; occult blood. 
Brain Function (Electroencephalogram and Polvsomnographv); The methods and procedures described below have 
received approval from the University of North Dakota Institutional Review Boardand the USDA Human Studies Committee 
for use in other studies performed at the GFHNRC. 
A. Awake State. Because published reports indicate that boron deprivation may affect brain electrophysiology (e.g., 
decrease tonic activation) and because experimentally-induced pain is reliably associated with changes in brain 
electrophysiology (e.g., increased delta frequency activity), the electrical activity of the brain while awake will be 
recorded by using standard electroencephalograph (EEG) techniques and procedures once during baseline and during 
weeks 6 and 10 of each dietary period for a total of three times during the study. A trained technician will fit the 
subject with a recording cap containing a standardized montage of electrodes to measure ongoing electrical activity 
at the scalp. Bipolar recording will be done by referencing scalp leads to an electrode attached with adhesive collar 
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and located over the mastoid bone behind the contralateral ear. A small amount of water-soluble glue will be applied 
to the scalp at each recording site to reduce impedance. The EEG will be recorded as the subject sits in a soundproof 
chamber located in the Psychology Laboratory and performs simple mental tasks (e.g., subtraction by 7's, visual and . 
auditory vigilance) or relaxes during eyes open and eyes closed periods. Visual tasks will be presented on a monitor 
and auditory tasks will be presented through stereo speakers. Overt responses will be ·registered by pressing buttons 
locatcd on the arm ofthe subject's chair. While in the EEGrecording chamber, the subject is observed by a technician 
on a closed-circuit television system and communicates with the technician via a two-way intercom system. EEG 
recording sessions require approximately 45 minutes to complete. 
B. Sleep State. Because changes in brain activation in response to dietary boron supplementation may be even more 
apparent during sleep than when awake, and because decreases in tonic nervous system arousal may affect sleep. 
quality or quantity, brain electrical activity during sleep will be assessed once during baseline and during week 10 of 
. each dietary period for a total of three times during the study. The electrical activity of the brain during sleep will 
be recorded by using standard polysornnographic [BEG, electrooculogram (EOG), electromyogram (EMG), and 
respiration] techniques and procedures. A total of 10 electrodes will be applied by a trained technician - two 
electrodes with a water-soluble gel to the scalp for EEG, two electrodes with adhesive collars near the outer canthi 
of both eyes for EOG, two electrodes with adhesive collars over the submentalis muscle of the chin and on~ electrode 
with an adhesive collar over the anterior tibialis of each leg for EMG, and one electrode with an adhesive collar over 
each mastoid as references. All ofthe above electrodes will be ofthe silver-silver chloride type. In addition, an oral-
nasal thermocouple and a strain gauge placed around the chest just over the breasts will be used to monitor respiration. 
Following electrode application, the subject will go to bed and all electrodes will be connected through a single multi-
conductor cable to an amplifier located at the head of the bed. The subject will be then allowed to sleep normally and 
will be free of visual monitoring throughout the night. Electrodes will be removed by a member of the nursing staff 
when the subject awakens in the morning. Room conditions will permit the subject to call a nurse at any time during 
the night if the subject needs to get out of bed (bathroom trips, etc.). To acclimate the subject to wearing electrodes 
during sleep, the subject will be fitted and will sleep with all electrodes one night prior to the first recording night. 
Therefore, the subject will actually participate in the polysomnography procedure a total of seven nights during the 
study, however, recording of subject electrophysiology during sleep \vill not exceed a total of six nights over the 
course of the entire study. The evening before and the morning after PSG, subjects complete a brief Sleep Behavior 
Inventory to record their mood and sleep quality and related characteristics (5 min) 
Psychological and Behavioral Function: The methods and procedures described below have received approval from the 
University of North Dakota Institutional Review Board and the USDA Human Studies Committee for use in other studies 
performed at the GFHNRC. Based on the hypothesis that dietary boron influences central nervous system arousal, it is likely 
that boron supplementation will affect performance and behavior. Therefore, sensory-motor and spatial skills, cognitive 
processes and mood states will be assessed. The forms listed below are commercially available and/or copyrighted tests with 
use restricted to qualified professionals. They will be provided to the IRB upon request. . 
A. Sensory-motor and spatial skills (e.g., eve-hand coordination) and cOQJlitive processes (e.g .. attention. memory and 
reasoning): Psychomotor and cognitive function will be assessed by using standardized tasks designed for "normal" 
populations and administered on a personal computer three times, once during each of the three dietary periods. Test 
sessions require approximately 60 minutes and will be performed under the guidance of a trained technician in a 
testing cubicle located in the Psychology laboratory at the Grand Forks Human Nutrition Research Center. Based on 
previous studies of other minerals, assessment of function in the following areas will be done, with the corresponding 
computer task(s) in parentheses: sensory-motor integration (visual pursuit), motor fatigue (tapping), planning and 
spatial orientation (two- and three-dimensional pattern matching), attention ( continuous vigilance), perception (object 
search, visual density comparison, color-word identification), encoding and working memory (symbol-digit), long-
term memory (object and pattern recognition), and reasoning (object classification). Subjects will be monitored by 
a trained technician while they perform the tasks to ensure compliance with task instructions ·and protocol. Not all 
tasks may be administered to all subjects due to time constraints. 
B. Mood states (e.g .. atL'(ietv. depression. hostility. vigor): Mood states will be assessed during the first dietary peliod 
and during weeks 6 and 10 of each of the second and third dietary periods for a total of five times during the study 
by using standardized paper-and-pencil tests designed to assess mood states in a normal population. These tests are 
purchased from commercial test publishers and administered in a group setting by a trained technician or psychology . 
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graduate student in accordance with all standards established for test administration, interpretation and confidentiality 
by the American Psychological Association. Test sessions are conducted in a comfortable, quiet room located in the 
metaboiic unit. Tests are untimed and typically require from 10 to 20 minutes to complete; thus, a test session lasts 
about 60 minutes. Based on previous studies of boron, administration of the following tests will be done: Multiple 
Affect Adjective Checklist, Spielberger State-Trait Anxiety Inventory, State-Trait Depression Adjective Checklist, 
Center for Epidemiology Study-Depression , BeckDepressionInventory and Spielberger State-Trait Anger Inventory. 
C. Historical and current pain. pain attitudes and daily activities. ' History of pain will be assessed with the McGill Pain 
Questionnaire during recruitment. Weekly, subjects will complete the 10 minute Multi.dimensional Health Assessment 
questionnaire. Daily throughout the study, subjects will report the location, intensity, aversiveness and duration of pain 
by using visual analog scales. Use of medications to provide pain relief will be recorded and analyzed. 
D. Sleep. intellectual and social functioning, verbal and auditory memory. and handedness assessments: made by the 
Psychology Laboratory staff members to facilitate the interpretation of data and to monitor subject psychosocial 
adjustment during participation in this long-term, live-in study and collected at the beginning of the study. Also at 
that time, the Lateral Preference Schedule will be administered to determine handedness and other aspects of 
dominance. Level of intellectual functioning will be determined by the 90-minute Multidimensional Aptitude Battery 
that will be administered to subjects as a group one time during the first month of the study. Once during the second 
and third dietary period, verbal and auditory memory will be measured with the 45-minute MemOlY Assessment Scale 
and social functioning will be determined by the 45-minute Interpersonal Behavior Survey. In addition, the 90-minute 
Minnesota Multiphasic Personality Inventory will be administered duJjng subject recruitment and at the conclusion 
ofthe study. 
Activitv Monitoring: Gross behavioral activity will be monitored continuously throughout the study by having subjects 
wear an Actiwatch (Mini Mitter, Sunriver, OR) that contains an accelerometer capable of sensing motion with a minimal 
resistance force. The Actiwatch will be worn above tlw wrist bone on either hand and secured by either a plastic or elastic 
band, at the subject's discretion. 
Vision and Auditory Function: To ensure that subject scores on tasks administered during awake EEGs and performance 
testing are not confounded by preexisting deficits in sensory function, vision and hearing will be assessed by using standard 
screening equipment and procedures during the first two weeks of the study. Binocular and monocular acuity, color vision, 
and stereo depth perception will be determined by using a Titmus Vision Tester, and one-ear and two-ear hearing abilities 
(air copduction only) will be determined by using a Beltone Audiometer. These tests require approximately 30 minutes and 
will be administered by a trained technician in a comfortable, quiet room located in the Psychology Laboratory at the Grand 
Forks Human Nutrition Research Center. 
Bodv Composition: Body composition measurements will be used to assess the relationship of boron metabolism to body 
size and to lean body mass in women. Thus, at regular intervals throughout the study, body composition will be determined 
by dual energy x-ray absorptiometry (soft tissue composition and bone mass), whole-body scintillation counting using a 
uniform isotope source (fat-free body mass) .anthropometry (height, weight, skinfold thickness, and circumference), and 
bioelectrical impedance (lean body mass). These methods or procedures are described below and have received approval 
from the University of North Dakota Institutional Review Board and the USDA Human Studies Committee for use in other 
studies performed at the GFHNRC. All of these procedures will be done at the Grand Forks Human Nutrition Research 
Center by experienced, specially trained staff members. In addition, the test administrator of the dual x-ray absorptiometry 
scan has been trained by Hologic, Inc. staff and is an USDA Radiation Safety Committee approved radiation user. 
A .. Soft tissue composition and bone mass. 
1. Dual X-Ray Absorptiometrv- This test will be performed to aid in the estimation of total muscle mass. The whole-
body measurement will be made by briefly exposing each volunteer to collimated low-level x-rays. These 
measurements will provide information about soft tissue composition (fat and fat-free, bone-free) ofthe whole body. 
The volunteer lies supine on a bed that moves over a tungsten stationary anode x-ray tube, pulsed alternatively at 70 
and 140 Kvp and operated at a tube current of2 milliamps peaks. The effective beam energies are 43 and 110 keY. 
The total time for a whole-body scan is less than 16 minutes. The whole body scan will be performed three times 
during the study. The radiation dose for each whole-body scan is 4.0 microSievert ()lSv) or 0.4 millirem (mrem) for 
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a total of 1.2 millirem. The DXA is calibrated on the day of scheduled testing by scanning a spine phantom which 
contains a known a mount of bone mineral (hydroxyapatite). Limits of agreement are + 1.5% of certified values. If 
data are outside of this tolerance, a representative from the manufacturer is contacted for service to the DXA. 
Volunteer scans are postponed until the DXA has been repaired. 
2. Whole-Bodv Scintillation Counting Using a Uniform Isotope Source (UNIS) - Potassium-40 is a naturally occurring 
radioisotope of potassium exclusively found in the fat-free body (muscles, bone and organs). Extemal counting of 
potassium-40 permits an estimation of changes in fat-free body mass. Three times during the study, the volunteer will 
lay supine on a mattress above and below which are suspended sodium iodide crystals used to count to gamma ray 
emissions from the body's natural burden ofpotassium-40. Because each volunteer's body size and shape may change 
with the boron dietary treatments, it is necessary to correct the measured counts of gamma ray emissions due to 
potassium-40 decay by exposing the volunteer to a uniform isotope source before each whole-body count to determine 
the body's burden of potassium-40. A sodium-22 (a radioactive form of sodium) source will be placed under the 
mattress for a one-minute count while the volunteer lies on the mattress. This procedure, which exposes the volunteer 
to a radiation dose of much less than 0.01 microsevert (0.00 I millirem), is necessary to obtain absolute measures of 
total body potassium that are independent of changes in body geometry. The total radiation dose for 3 repetitions of 
this procedure is less than 0.03 microsevert (0.003 mrem). This test permits an assessment of changes in body cell 
mass during the boron-low and boron-adequate dietary periods. 
B. Anthropometrv - This test is performed three times during the study to aid in the estimation of body composition and 
body physique. Standing height or stature and body weight will be determined. Measurements of skinfold thickness 
at triceps, biceps, subscapular, midaxillary, calf, mid-anterior thigh, juxta-umbilical and iliac sites; bichondylar 
diameters and circumferences at the wrist, humerus and femur, calf, thigh, waist, hips, upper and lower arm will be 
made twice during the study. 
C. Bioelectrical Impedance - Measurements are made for validation of this technique to predict body composition and 
fluid distribution. Whole-body and regional impedance variables will be determined three times during the study 
during the study with a single- (50 kHz; RJL Systems; Mt. Clemens, MI) and again with multi-frequency (1kHz to 
I MHz; XITRON; San Diego, CA) impedance device. This measurement is made with the volunteer supine on a non-
conductive table with the arms and legs abducted from the body and the fingers extended. Small, adhesive electrodes 
are placed on the hands and feet, upper and lower arm, and thigh for whole-body and regional or limb measurements. 
A constant current source introduces a safe, painless, non perceptible, radiofrequency, alternating current of 100 
microamps at frequencies ranging from I kilohertz to 1 megahertz into the. distally-positioned electrodes on the hand 
and foot and the voltage drop is measured at the proximally-placed electrodes. 
Both single- and multiple frequency instruments are calibrated with an approved equivalent circuit (calibrator) 
consisting of precision resistors and capacitors. The instruments are calibrated before each test of a volunteer. 
Tolerance· is within 1% certified values of resistance, reactance or impedance. If measurements on the calibrator 
exceed 1%, the device is returned to the manufacturer for repair. Volunteers undergo bioelectrical impedance 
measurements only after the devices have been restored to correct operation. 
Health Status Surveillance: If, during the course of the study, a health variable moves out ofthe nOlmal range, the subject 
and the test results will be sent to a Center-selected physician at no cost to the subject. 
Adverse Reactions or Health Problems: Adverse reactions are unlikely, and but could include problems such as food 
intolerance, faintness with blood draws, or common health care problems unrelated to the research, such as infectious 
illnesses, muscle strain, physical injuries, or previously unrecognized health problems. Each situation will be handled 
individually, with all relevant information discussed with the volunteer. The volunteer may be advised to consult with a 
physician, at the expense ofthe research center if related to the research, or at their own expense if unrelated to the research. 
For physician consultations initiated by the Center, transportation within a I OO-mile radius of the Center will be paid for by 
the Center. If a volunteer insists on a visit outside of those limits, they will most likely be dismissed from the study. No 
health-related information will be provided to a health care center without the express written consent of the volunteer. If 
the problem interferes with the research, or ifthe volunteer no longer meets the research criteria of being generally healthy, 
then the volunteer will be dismissed from the study. lfthe problem does not interfere with the research, then continuation 
will be at the volunteer's discretion. Temporary variances in procedures (e.g. missed or delayed meals or testing) may be 
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allowed if they do not interfere with the main objective of the research, but the volunteer will not be pressured to remain in 
the study. 
Emergencv Response: The Altru Health System's ambulance (located 1 mile away) will be called for emergency medical 
care. The Grand Forks police and/or fire department will be called as needed. First aid supplies, fire extinguishers and fire 
blankets are available. Full-time staff includes a CPR-certified nurse staffIng the Metabolic Unit around the clock, a 
physician who is certified in Advance Cardiac Life Support, and a chemical safety officer. Policies and procedures for 
Emergency Response (including fire, bomb threats, and tornado) are in place for the Center. 
Premature Dismissal Criteria: Subjects found to willfully and/or significantly disregard any rule or guideline mandated 
by the study or unilaterally elect, for any reason, to end involvement in the study prior to natural termination of the study will 
be dismissed at the earliest convenience of the Center and at no physical jeopardy to the subject with full forfeiture of 
unearned per diem. If the Center determines that continued involvement in the study might be harmful to the physical or 
mental state of a subject or if development of an illness or a condition might affect the research results, the subject will be 
dismissed at the earliest convenience ofthe Center and at no physical jeopardy to the subject with full forfeiture of unearned 
per diem. 
3. BENEFITS: (Describe the benefits to the individual or society.) 
Direct benefits include the satisfaction from participating in a worthwhile research study that win benefit humanity because 
it will advance knowledge about the importance of boron for health and well being, especially as it relates to the control of 
rheumatoid arthritis. Information may be used to plan better diets or to. change the dietary recommendations for boron. In 
appreciation for the participation ofthe volunteer, she win receive $35 per day to be paid every two weeks. The total amount 
of the honorarium that the volunteer will receive if they complete the study will be $5,880. 
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4. RISKS: (Describe the risks to the subject and precautions that will be taken to minimize them TIle concept of risk goes beyond physical risk 
and includes risks to the subject's dignity and self-respect, as well as psychological, emotional, or behavioral risk. If data are 
collected which could prove harmful or embarrassing to the subject ii associated with him or her, then describe the methods to be used 
to insure the confidentiality of data obtained, debriefing proceaurcs, storage of data for the required three years, final disposition of data, etc.) 
Living Environment: Group living on the Metabolic Unit and following the study procedures will result in appreciable loss 
of freedom and privacy. Their life will be much more regimented. They will lose much of their individual choices because 
the diet, many living conditions (such as meal times, waking time, sharing a bathroom, and escorts when off the Unit), 
procedures, and activities are decided by the study protocol and unit rules. 
Rheumatoid Arthritis Therapies: All obligatory RA therapies during the study are those prescribed by a physician or 
volunteer-selected prior to entry into the study. As such, the therapies are a continuation of previous therapies, not new 
treatments. 
Rheumatoid Arthritis (RA) Flare: In the unlikely case of an RA flare, strategies to ameliorate the flare will supercede 
requirements of any research objective. All relevant information will be discussed with the volunteer. Each case involving 
an RA flare will be handled individually. If a nare-up occurs, the volunteer will be seen by a physician to ensure that the 
condition is treated. With the volunteer's permission, all data will be sent the volunteer's primary physician, in their 
hometown, as soon as it becomes available and that physician will be continually updated on the volunteer's state. 
Boron Content in Diet: Boron deprivation impairs reproduction of lower vertebrates, exacerbates the rachitic state, and 
increases the severity'of experimental rheumatoid arthritis in an animal model. In humans, boron deprivation reduces vitamin 
D metabolite serum concentrations, decreases brain electrical activity similar to that observed in nonspecific malnutrition, 
decreases performance in tasks of motor speed and dexterity, attention and short-term memory. There is no Recommended 
Daily Allowance for boron because the requirement for boron has not been determined. Past studies with postmenopausal 
women at this Center indicate that it is not difficult to achieve a reduction in blood boron concentrations. However, 
symptomatic human boron deficiency has not been defined and severe or marked indications of boron deficiency were not 
noted in any previous metabolic study with volunteers. Findings from animal model systems indicate that any human boron 
deficiency symptom will be more pronounced when there are concurrently nutritional or physiological stressors. In 
conjunction with a magnesium-low intake (109 mg/d), a daily boron intake of 0.36, compared to 3.23 mgper day (comparable 
to that in a diet with fruits, vegetables, and legumes), decreased systolic and diastolic blood pressure but within the 
physiological range, and lengthened the QRS complex. 
merimental Diets: Every effmi has been made to provide palatable diets acceptable to most people. However, some 
subjects are likely to become tired of consuming the same limited number offoods every third day for 168 days. Although 
the experimental diets will provide less food variety than the average U.S. diet, they will otherwise be no more likely to result 
in nutrient deficiency or dietary risk than the typical U.S. diets. The calculated nutrient content of the diet will be adjusted 
by dietary supplements ifnecessary to meet average intakes of alllmown essential nutrients (except boron) as estimated by 
a national food intake survey. 
Cardiac Monitoring.;. There are no known risks associated \vith ambulatory cardiogram monit0l1ng and 12-lead EKGs. 
However, some individuals may experience skin irritation from the electrode placement. If skin irritation occurs, various 
skin care measures will be used and alternates sites used. To protect the volunteer from possible halm, significant Holter 
electrocardiographic (ECG) changes will be cause for stopping boron depletion and starting boron repletion. The ECG 
changes considered significant include: 1) For the volunteer who initially has 0 or 1 ventricular premature discharge (VPD) 
during the first two Holters, an increase to 5 VPDs per 20 hours will considered an aggravation. 2) For the volunteer who 
has 2 or more VPDs during the first two Holters, an aggravation has occurred when there is a four-fold increase in VPDs or 
a ten-fold increase in repetitive forms. 3) The appearance of rhythm abnormalities not present during the first two Holters 
such as atrial fibrillation, A V block and tachycardia. Confirmation of rhythm changes will be by a second Holter ECG done 
after detecting the changes for the first time and will be investigated by use of a 12-lead ECG. 
Noninvasive Joint Function Assessment: The Purdue Pegboard procedure is expected to cause transient pain but similar 
to that associated with typical daily activities involving fine motor skills. The normal end-feel during range of motion 
assessments of normal joints is either hard, firm, or soft depending on respective bone-bone contact, tension ofligaments, 
or compression of muscle bulle. In assessment of RA-affected joints, motion in the appropriate plane to reach end-feel is 
terminated at the first sign of subject discomfort. 
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Resting Energv Expenditure (REE): There are no known risks associated with this 'procedure. The participants may 
experience some minor discomfort with the equipment used to collect respiratory gases. 
Venipuncture: There may be some discomfort as the needle enters the skin, but this lasts only a few seconds. About 10% 
of the time a small bruise may develop at the needle site, but this resolves in two weeks or less. Less than 0.1 % of the time 
the site may become infected, but this is easily treated with antibiotics. One hundred twelve (112) mL will be drawn five 
times, 13 mL will be drawn 8 other times, and 24 mL will be drawn two other times for a total of712 mL or about 1.5 pints 
over 24 weeks. A maximum of287 mL of blood will be taken within an eight-week period. TIus is considerably less than 
blood bank donation limits of 475 mL every eight weeks and is needed to ensure that the anemia sometimes associated with 
rheumatoid arthritis does not strengthen if present. The normal range of hemoglobin for females ages 18-49 years is 12.0-
16.0 mg/dL. Slight anemia cs. 10 g ofhemoglobinldL) is often present during the initial diagnosis ofrheurnatoid arthritis. 
However, hemoglobin concentrations were 12.7 ± 0.6 mgldl in both classes (either receiving or not receiving methotrexate) 
of male and female subjects with inflammatory arthritis in a study reported in 1996. To prevent possible anemia from 
strengthening or from developing, the iron content of the diet has been elevated to about 25 mg/day. Nonetheless, the iron 
status of the subjects will be monitored. The blood volume withdrawn will be reduced to that needed for determination of 
health status if 1) an initial hemoglobin of.::=: 10 mg/dL falls below 10 mg/dL or 2) an initial hemoglobin of:::: 10 mg/dL falls 
> 10% of the initial value. If this does not alleviate the anemic state, the subject will be evaluated by a local physician and 
given supplemental iron as prescribed. 
Boron Stable Isotope Administration: There are no known risks associated with consumption ofa natural boron isotope 
via incorporation into broccoli other than possible transient intestinal gas and bloating associated with broccoli consumption 
per se. The presence of an indwelling catheter for 4 hours will cause some distress and is similar to that used by clinics for 
a glucose tolerance test. 
Urine and Fecal Collection: There are no known risks associated with these procedures. There may be odor from the urine 
and fecal collection. This can be minimized by keeping the samples cool in the refrigerator provided for this purpose in the 
, volunteer's bathroom. 
Brain Function (Electroencephalograpby and Polvsomnographv): There are no known risks associated with 
electroencephalography orthe collection of otherelectrophysiologic data related to polysomnography as proposed. However, 
some individuals may experience mild, transient discomfort during electrode placement on or removal from the scalp, face, 
neck and legs. 
Psycbological and Behavioral Function: There are no known risks or discomforts associated with the assessment of 
sensory-motor and spatial skills, cognitive processes, motor tremor or mood states. If there are any concerns regarding 
psychological and behavioral assessments the subject may discuss these with the psychologist or psychology research 
assistants (supervised by a licensed clinical psychologist), with whom she will be meeting on a regular basis. 
Activitv Monitoring: There are no known risks or discomforts associated with activity monitoring. 
Vision and Auditorv Function: TIlere are no known risks or discomforts associated with the vision or hearing tests. 
Psvchology Debriefing Procedure: During the last week of the study, the Research Psychologist and other psychology staff 
will meet with each research subject individually, and in ~oups when appropriate, to present to her all available performance, 
psychological and electrophysiological data collected on her, to provide interpretation of results when appropriate, and to 
receive feedback concerning all testing done by the Psychology Laboratory. Care will be exercised to stress individuality 
in performance and the fact that comparisons are within rather than between subjects. Therefore, presentation of normative 
data will rarely be done. Experience with this debriefing process indicates that subjects greatly appreciate this discussion 
of their data and leave the study satisfied in knowing what data was collected and why, and how they performed on the 
various tests and tasks administered throughout the study. 
Bodv Composition: 
A. Soft tissue composition and bone mass. 
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1. Dual X-Rav Absorotiometry: The total radiation dose in this procedure is less than 1.5 mrem. This is approximately 
15% of the radiation exposure incurred during a chest X-ray. It is equivalent to spending 8 hours in ajet airplane 
at a cruising altitude of 25,000 feet or spending approximately 1.5 weeks in the Colorado plateau area. The 
procedure will be performed three times and results each time in exposure ofless than 0.5 mrem. Average annual 
radiation exposure in the United States is 360 millirem per person. The lowest dose estimated to provide good 
analytical precision has been calculated for use in the study. Two concerns about radiation exposure are that it can 
cause cancer or shorten life. A report (BEIR V, 1990) summarizing the effects of radiation, based mainly on 
survivors in Japan of World War II atomic bombs at Hirosillma and Nagasaki, has indicated that an acute total body 
dose of 10,000 mrem would cause approximately 800 excess cancer deaths and 14,500 years oflife lost per 100,000 
persons. If the effect of radiation at high doses is assumed to be proportional to the effect at low doses, the 1.5 
mrem dose received in tills study could result in 0.125 "extra" cancer deaths per 100,000 people and reduce life span 
by an average of 11.5 minutes per person. However, it is impossible to accurately estimate the excess deaths 
because a 1.5 mrem dose is an insignificant exposure when compared to the lifetime exposure of about 24,000 mrein 
from natural sources such as cosmic rays and radon. 
2. Whole-Body Scintillation Counting Using a Uniform Isotooe Source (UNIS): The radiation dose in this procedure 
(0 .001 mrem) is extremely low, approximately 700 times less than the daily radiation exposure from natural 
background radiation sources (0.7 mrem). 
B. Anthrooometry - There are no known risks involved in the anthropometric and skinfold thickness measurements. 
However, some individuals may experience transient, minor discomfort during the measurement of skinfold thickness. 
C. Bioelectrical Impedance -There are no known risks associated with this procedure. 
Confidentialitv of Data Handling: To reduce the risk oflosing privacy of personal information, confidentiality will be will 
be stressed with all staff members involved. Each volunteer will be assigned an identification number that is used to 
anonymously identify data. Staff will enter collected data into a password-coded computer system using only the volunteer 
identification number. All the consents, personal infOlmation, and medical data will be kept in a locked file at the Grand 
Forks Human Nutrition Research Center for at least three years after completion of the study. Access will be limited to 
approved staff members. Upon disposal, any paper that contains names and/or personal information will be shredded. 
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5. CONSENT FORM: Attach a copy of the CONSENT FORM to be signed by the subject (if applicable) and/or any statement to be read to the 
subject. Ifno CONSENT FORM is to be used, document thc procedures to be used to assure that infringement upon the 
subject's rights will not occur. 
Describe where signed consent forms will be kept for the required 3 years, including plans for final disposition 
or destruction. 
A copy of the consent form is attached. The informed consent is distributed when a small (approximately 30) contingency 
of prospective volunteers are brought to Grand forks for an on-site visit. The prospective volunteers take the consent fonn 
home and those selected to participate in the study bring the form with them when they return to Grand Forks. The form is 
signed the day they enter the study. Signed consent forms and data will be kept at the Grand Forks Human Nutrition Research 
Center in a locked file for at least three years after completion of the study. Our current policy is to keep all consent forms 
indefinitely. If future technology facilitates another secure medium for storage of these forms, paper copies will be shredded. 
6. For FULL IRE REVIEW forward a signed original and fifteen (IS) copies of this completed form, including fifteen (15) copies of the proposed consent form, 
questionnaires, examples of interview questions, etc. and any supporting documentation to the address below. An original and 19 copies are required for clinical 
medical projects. [II cases where the proposed work is part ofa proposal to a potential funding source, one copy of the completed proposal to the funding agency 
should be attached to the completed Human Subjects Review Form if the proposal is nOIl·clinical; 7 copies if the proposal is clinical medical. 
Office of Research & Program Development 
University of North Dakota 
Grand Forks, North Dakota 58202-7134 
On campus, mail to: Office of Research & Program Development, Box 7134, or drop it offat Room lOS Twamley Hall. 
For EXEMPT or EXPEDITED REVIEW forward a signed original, including a copy of the consent form, questionnaires, examples of interview questions, etc. and 
any supporting documentation to one orthc addresses above. In cases where the proposed work is part of a proposal to a potential funding source, one copy of the 
completed proposal to the funding agency should be attached to the completed Human Subjects Review FOtm. 
The policies and procedures on Use of Human Subjects ofthe University of North Dakota apply to all activities inVOlving use of Human Subjects performed by personnel 
conducting such activities under the auspices of the University. No activities arc to be initiated without prior review and approval as prescribed by the University's policies 
and procedures governing the use of human subjects. 
SIGNATURES: 
~P-n~'n-c~i-p-al~In-v-e-s-u-'g-a-to-r------------------------------------------------------+~I~------~D~a-t-e--------~I · 
Pro' ect Director or Student Adviser Date 





INFORlVlED CONSENT STATEMENT 
Physiologic Amounts of Diet my Boron as a Factor in the 
Manifestation of Rheumatoid Arthritis . 
Study 143 Written 2-11-00, Revised 5-22-00, 11-15-00, 10-3-01 
Curtiss D. Hunt, Ph.D., Joseph B. Sleckman, MD, James G. Penland, 
Ph.D., Henry C. Lukaski, Ph.D. 
UNITED STATES DEPARTMENT OF AGRICULTURE, 
AGRICULTURAL RESEARCH SERVICE 
GRAND FORKS HUMAN NUTRITION RESEARCH CENTER 
Box 9034,2420 2nd Ave. N. 
Grand Forks, ND 58202 
Phone 701-795-8353 or 1-800-562-4032 
This is an important form. Please read it carefully. It tells you what you need to know 
about this study. If you agree to take part in this research study you need to sign the form. 
Your signature means that you have been told about the study and what the risks are. 
Your signature on this form also means that you want to take part in this study. 
Am I Eligible for this Study? 
You are invited to participate in this -research study designed to establish that dietary 
boron is important in .. alleviatingtht:symptoms of rheumatoid arthritis. Weare extending this 
invitation because: 
1 ) You are a woman who does not smoke and are not an alcoholic .. 
2) You have active, but stabilized, rheumatoid arthritis as certified by your personal 
physician. 
3) You do not show advanced indications 0 f rheumatoid arthritis. 
4) You are taking methotrexate for rheumatoid arthritis and rheumatoid arthritis therapy 
only as prescribed by a physician. 
5) The dosage of methotrexate has been stable over the last 4 months before the start of the 
study. 
I have read this page and agree with the content __ 
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6) The only additional therapies that you currently take for your rheumatoid arthritis (if at 
all) besides methotrexate are: 
a) nonacetylated salicylates (like Disa1cid) for pain or swelling. Exceptions will be 
made at the discretion of the principal investigator. 
b) acetaminophen (like Tylenol) 
c) prednisone or its equivalent, 
d) hormone replacement therapy (like Premarin) 
e) or some combination of one or more of these therapies. 
7) The dosages of the additional therapies has been stable over the last 4 months before the 
start of the study. 
8) You ceased taking acetylated salicylates (like aspirin) four weeks before the start of the 
study for relief of inflammation and pain, 
9) You are in good mental health, 
10) . You are fully able to walk around unassisted and are able to carry out non-assisted 
bodily toilet, showering, and washing functions, collection of all urine and stool materials 
(as described below), and consumption of all foods, beverages, nutrient supplements, and 
medications, 
11 ) You have no chronic condition or illness other than rheumatoid arthritis. 
I have read this page and agree wilh the contenl __ 
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Why is this Study being Done? 
Boron is a mineral that plants need for life. It is also necessary for the reproduction of 
frogs and fish. In chicks with rickets (vitamin D deficiency), boron makes their bones grow 
straighter. In rats with a form of rheumatoid m1hritis, boron reduces swelling in the paw. For 
women, there is no recommended dietary boron allowance although their daily intake of boron is 
estimated to be 0.73 milligram per day. A milligram is a measure of weight far smaller than an 
ounce; two poppy seeds weigh a milligram. Postmenopausal women ingesting 0.36 milligram of 
boron per day are prone to net boron loss as determined by a balance study. Balance is the 
measurement of boron taken in minus the amount excreted in the mine and feces; this value 
should be slightly positive during growth and near zero when body size and composition is being 
maintained. 
The study that you have agreed to participate in will establish whether normal amounts of 
boron in the diet changes your symptoms ofrhemnatoid arthritis. By measuring whether you 
lose or keep much more of a mineral than you take in, we will be able to substantially improve 
our ability to provide nutritional counseling to patients with rheumatoid arthritis. 
How Long will I be in the Study? 
The study lasts for 168 days (24 weeks). 
What are the Living Conditions? 
Except for periodic visits to a physician, the study will be carried out at the Grand Forks 
Human Nutrition Research Center (GFHNRC) which has a metabolic unit that will accommodate 
14 volunteers for long-term, live-in studies. You will have a private bedroom with cable 
television, intercom to a nursing station, a radio, a telephone, and a semi-private bathroom. 
I have read this page and agree with the conient _. _ 
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In case you experience a rheumatoid arthritis flare-up that affects your ability to walk, you will 
have access to a walking aid for use and staff assistance in your room or bathroom, but only a 
non-motorized wheelchair escorted by a staff member outside of those areas, 
We will give you a list of personal care items (like toothpaste) that are acceptable by us 
for you to use. In your free time, you may leave the Center only when accompanied by a 
chaperone provided by the Center. Priority will be given to scheduled meals and tests. Your 
cooperation and attention to the rules and regulations governing your conduct on the Metabolic 
Unit are expected. A nurse will be present on the metabolic unit 24 hours a day and a physician 
and psychologist will be on call for any problems (medical or otherwise) which may mise. 
What Medications Can I take? 
All rheumatoid arthritis treatments approved by us are provided to you at no cost and are 
stored, dispensed, and inventoried by nurse on duty. All medications must be consumed in the 
presence of the nurse. You agree to take only those treatments for rheumatoid arthritis that we 
approve. These are the following: 
Tl"eatment Agreement Agree (chcck if 
you agree) · 
Oral Methotrexate You certify that you took oral methotrexate for 
rheumatoid arthritis and for rheumatoid arthritis only 
as prescribed by a physician for at least one year before 
the start ofthe study. 
You certify that the dose of methotrexate has been 
constant for at least the last 6 months before the 
beginning of the study. 
You agree to keep taking the same brand, form, and 
dosage of methotrexate as you were last prescribed by 
your physician before entry into the study. 
I have read this page and agree with the content __ 
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Oral Prednisone If you took prednisone (or equivalent) before the 
(or eguivalent} beginning of the study, you agree to keep taking the 
same brand, form, and dosage of prednisone (or 
Like: equivalent) as you were last presclibed by your 
Deltasone physician before entry into the study EXCEPT during a 
Prednicen-M rheumatoid arthritis flare-up certified and treated by a 
Sterapred physician. 
If you DID NOT take prednisone (or equivalent) before 
the beginning of the study, you agree to NOT start 
taking prednisone or equivalent at any time during the 
study EXCEPT during a physician-certified 
rheumatoid arthritis flare-up. 
Oral If you took nonacetylated salicylates (like Disalcid) or 
N onacetvlated other drugs for pain and swelling approved by the 
Salicvlates principal investigator before the beginning of the study, 
you agree to keep taking the same brand, form, and 
Like: dosage of these therapies for rheumatoid arthritis as 
Disalcid, choline you were taking before entry into the study EXCEPT 
magneslUm during a rheumatoid arthritis flare-up certified and 
trisalicy late, treated by a physician. 
Magsal, 
Pabalate, If you DID NOT take these drugs before the beginning 
salsalate or of the stI;tdy, you agree to NOT start taking 
Salf!.ex nonacetylated salicylates at any time during the study 
EXCEPT during a rheumatoid arthritis flare-up 
certified and treated by a physician. 
Oral If you took acetaminophen (like Tylenol) before the 
Acetaminonhen beginning of the study, you agree to keep takingthe 
same brand, form, and dosage of approved 
Like: acetaminophen as you were taking right before entry 
Anacin-3, into the study EXCEPT during a rheumatoid arthritis 
Extra-Strength flare-up certified and treated by a physician. 
Tylenol 
If you DID NOT take acetaminophen (like Tylenol) 
before the beginning of the study, you agree to NOT 
start at any time during the study EXCEPT during a 
rheumatoid arthritis flare-up certified and treated by a 
physician. 
I have read this page and agree with the content __ 
61 
Physiologic Amounts of Dietary Boron as a Factor in the Manifestation of Rheumatoid Arthritis 
Hormone You certify that, if you take homlOne replacement 
Replacement therapy, it was started and held constant for at least 4 
Therapy months before the beginning ofthe study. 
If you took honllone replacement therapy (like 
Premarin) before the begim1ing of the study, you agree 
to keep taking the same brand, fonn, and dosage of 
honnone replacement as you were taking right before 
entry into the study EXCEPT during a rheumatoid 
arthritis flare-up certified and treated by a physician. 
You agree NOT to start honnone replacement therapy 
after the study has started. 
Other therapies You agree NOT to continue nor start any other 
for Rheumatoid traditional or non-traditional therapy or treatment for 
Arthritis rheumatoid arthritis other than the drug listed in this 
table after the study has started EXCEPT during a 
rheumatoid arthritis flare-up certified and treated by a 
physician. 
What Will I Eat? 
A. A three-day menu rotation. During the course ofthe study, you will be fed a diet made from 
common foods and ingredients that can be bought at a regular grocery store. The diet will 
contain all known nutrients necessary for life in the amounts similar to that consumed by 
women (except for boron for part of the time) as estimated by a national food intake survey. 
The diet will be served on a three-day menu rotation for 168 days. Women 60-65 years old 
are estimated to consume 0.73 milligrams of boron daily. At the beginning of the study, you 
will be fed the diet containing 2.0 milligram of boron per 2000 calories per day for 14 days. 
F or the next 77 days, you will, by random selection, either remain on this boron 
supplemented diet (2.0 milligram of boron per 2000 calories) or go to the boron non-
supplemented diet so that your boron intake will be about 0.3 milligram of boron daily. 
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For the final 77 days, you will switch to which ever diet you did not consume during the previous 
77 days. You will be expected to consume onlv and completelv the food, drink, and mineral or 
vitamin supplements provided by the GFHNRC dietary staff. 
B. Food intake/calories adjustments. At your written request, and after consultation with the 
dietary staff, the number of calories in your diet may be adjusted either upward or downward 
in 200 calorie increments two weeks after the request was made. However, body weight loss 
will be limited to -2% of initial body weight and will be corrected by 200 calorie increment 
increases. Body weight gain is acceptable. Your body weight will be measured regularly. 
C. A broccoli test meal. Twice during the study after an overnight fast, you will consume a 
quantity ofwann, cooked broccoli that has been grown in a mineral water solution. The 
broccoli contains mainly just one normal kind ofthe mineral boron instead of the usual two 
so that we can determine how fast boron is taken up by the body and then excreted. What 
Will Happen in the Study? 
Cardiac Monitoring: Your blood pressure, pulse, and temperature will be taken 
regularly. On a regular basis throughout the study, your hemi beat will be monitored for 20 
hours by an electrocardiogram (ECG or EKG) by using a hemi beat recorder. This machine, 
worn as a belt, is a small tape recorder that records the electrical activity of your heart for 20 
hours through foam adhesive electrodes temporarily attached to your chest. You will be free to 
move around and to go off the metabolic unit while wearing this machine. Twelve-lead resting 
electrocardiograms may also be done. This takes about 15 minutes, lying on a cot with 
electrodes on your chest. 
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Noninvasive RA Feature Assessment: On a daily basis, you will self-record the degree 
of morning stiffness and the location of all joints that are swollen or painful. On a daily basis 
you will fill out a questionnaire that asks whether you are experiencing night pain, fever sweats, 
weakness, dry eyes, or dry mouth. On a daily basis, the staff will examine your hands and wrists 
for swollen joints and nodules under the skin. The staff member will determine the volume of 
each hand by placing each in a graduated cylinder filled with water. To monitor the status of your 
rheumatoid arthritis, the staff will examine you, on a daily basis, for nailfold blood vessel 
clotting, skin ulcers, inflamed eyes, hand redness, red spots on the face. At the same time, they 
will ask you whether you have any chest pain, tenderness in the spine, or dry mouth. 
Each week, the staff will inspect all limb, jaw, and upper chest joints on your body for 
evidence of swelling, tenderness, stress pain, and damage, and will test all wrist, hand, finger, 
and thumb joints for range of movement. Every other week, the staffwill test your grip strength 
by having you squeeze a rolled blood pressure cuff 
Five times during the study, you will I) visit a physician who will conduct a physical 
examination to monitor your rheumatoid arthritic state, 2) place small pegs in a pegboard for 
assessment of manual dexterity, 3) hold a stylus inside a series of holes of decreasing diameter 
without touching the sides of the hole. 
Resting Energy Expenditure: Once during the first three weeks, then monthly 
thereafter, your lung gases will be measured before you eat in the morning while you rest in a 
reclining position and after you have let your body rest for 30 minutes. You will breathe through 
a face mask, similar to an oxygen mask, while the lung gases are being collected and measured. 
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Blood Draws: 
A. Regular blood draws. Blood will be taken :6:om a vein in your arm 13 different weeks 
so that the amount of various minerals, vitamins, and other important substances it 
contains can be measured. Some of these measurements will be used to assure that 
no harm to your health is occurring; others will tell ifboron is of practical nutritional 
importance for rheumatoid arthritics. Trained technicians or registered nurses use 
standard needles and syringes similar to those used in hospitals and clinics to obtain 
blood. A 13 milliliter (0.9 tablespoons) sample will be drawn 8 of the 13 times and 
ail 112 milliliter (7.5 tablespoons) sample will be drawn 5 of the 13 times over 24 
weeks. All blood will be drawn after an overnight fast (usually 12 hours) and before 
breakfast. 
B. Measuring boron movement through the body. Twice during the study, we will 
determine how fast boron is absorbed and moves through your body into the urine 
after it is eaten as a special broccoli test meal (discussed below). A needle will be 
inserted into a vein in your aIm and taped in place for 4 hours. This will be done in 
the morning before breakfast after you have fasted overnight. The needle in your 
vein will be kept open with normal saline solution between blood draws and before 
each blood draw a small amount (1.5 mL) of blood which contains saline will be 
discarded. This does not cause any discomfort beyond that of needle or catheter 
insertion and is the same procedure used in hospitals. You will be given a serving of 
broccoli prepared as described below (see Boron Stable Isotope Administration). 
Blood samples of2.5 milliliter (0.2 tablespoon) will be withdrawn through the 
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infusion set in your arm before you are given the broccoli serving and at five 
intervals afterwards for a period of four hours. A total of24 milliliter (1.6 
tablespoons) will be taken for each of the 2 tests. Four hours after completion you 
can eat the next regular meal. 
C. Total blood volume. The total amount of blood taken during the entire study is for a 
total of712 milliliter or about 1.5 pints. A maximum of287 milliliter (0.6 pints) of 
blood could be taken within an eight-week period. This is less than the blood bank 
donation limits of 475 milliliters (1 pint) evelY eight weeks. 
Boron Stable Isotope Administration: You will be expected to eat a serving of broccoli 
twice during the study. The broccoli was grown in a greenhouse in a water solution with all the 
normal nutrients for growth. The broccoli was given only one kind of natural boron. After you 
eat the broccoli, the natural boron will be absorbed and will pass through the blood stream before 
it is excreted in the urine. You will be asked to void at 0, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 12, and 24 
hours. The blood (described above under Blood Draws; Measurement of Boron Movement 
Through the Body), urine and ~tool samples are analyzed for boron to determine how fast the 
boron was absorbed, then excreted in the urine. 
Urine and Stool Collection: You will be expected to collect all your stool and urine 
throughout the study in bags and containers provided by the Center. These will be analyzed to 
determine the excretion of important minerals, including boron, magnesium, and calcium, that 
may be affected by the dietary manipulations. 
Brain Function (Electroencephalogram and Polysomnographv): The electrical 
activity of your brain while awake will be recorded three times during the study by using an 
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electroencephalogram (BEG), A trained technician from the Psychology Laboratory will fit you 
with a cap resembling a swimmer's cap, which contains numerous electrodes (sensors) designed 
to measure ongoing electrical activity at the surface of your scalp, A reference electrode will be 
attached on the bone behind each ear using an adhesive collar and a small amount of conductive 
gel will be applied to your scalp to help with recording. While your EEG is being recorded, you 
will sit in a sound-proof chamber and either relax or perform simple mental tasks (for example, 
counting by 7's, watching a television screen for a certain letter to appear, listening to a series of 
tones for a certain sequence to occur). While in the EEG recording chamber, you will be 
observed on a closed-circuit television system and may communicate with the technician at any 
time via a two-way intercom system. The EEG recording session will require about 45 minutes. 
Three times during the study, for two consecutive nights each, you will have your brain's 
electrical activity recorded while you sleep. Your eye movements, muscle tension, and 
respiration will be monitored simultaneously. This procedure, called polysornnography (pSG), is 
a simple one. Electrodes (sensors) will be attached to several locations on your scalp, face, neck, 
and legs. Also, an elastic band sensor will be plact;d around your chest to measure breathing. 
All electrodes will be attached by using a non-irritating adhesive and a small amount of 
conductive gel will be applied to each electrode to help with recording. A trained technician will 
apply the electrodes, you will go to be~, and the electrodes will be connected to a small box at 
the head of your bed. For the remainder of the night, you will allowed to sleep as you normally 
would, undisturbed and without observation. Should you need to get up during the night (for 
example, have to go to the bathroom), you can call the nurse over your intercom and the nurse 
will come to your room to disconnect your electrodes from the box. The electrodes will be 
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removed by a nurse when you first awaken the next morning. To familiarize you with the 
recording procedure, you will sleep with all el~ch·odes on one night prior to the first recording 
night. Therefore, counting the six recording nights, you will participate in the PSG procedure a 
total of7 nights during the course of the entire study. 
Psvchological and Behavioral Function: A variety of psychological and behavioral 
assessments will be done on a regular basis throughout the study. Sensory-motor and spatial 
skills (for example, eye-hand coordination) and cognitive processes (for example, attention, 
perception, and memory) will be tested three times during the study by having you perform 
simple tasks on a personal computer. Examples oftasks include tapping a key on the keyboard, 
using a computer mouse to track an object moving across the computer screen, searching a group 
of common objects for two of a kind, memorizing and recognizing lists of words or simple 
geometric patterns, and categorizing objects. Test sessions require about 60 minutes and are 
performed under the guidance of a trained technician in a testing cubicle located in the 
Psychology Laboratory at the GFHNRC. Following completion of the computerized tasks, we 
will assess motor tremor by measuring hand steadiness; this brief procedure requires about 10 
minutes. You will also complete the brief (about 5 minutes) Multiple Mfect Adjective 
Checklist. 
Other psychological assessments will be made by having you complete paper-and-pencil 
questionnaires. Weekly throughout the study, you will complete the Multi-Dimensional Health 
Assessment Questionnaire, a measure of arthritis-related pain, fatigue, helplessness and global 
health; this questionnaire requires about 10 minutes. Five times during the study, you will 
complete the State-Trait Anxiety Inventory, State-Trait Depression Adjective Checklist, Center 
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for Epidemiological Studies Depression Scale, Beck Depression Inventory and State-Trait Anger 
Inventory; total time to complete all five questionnaires will be about 60 minutes. Three times 
during the study, you will have your verbal and auditory memory evaluated with the Memory 
Assessment Scale; this evaluation will require about 45 minutes. Once at the beginning of the 
study, you will complete a sleep history and a questionnaire about hand and eye dominance. 
Later in the study, you will also be administered an intelligence test (Multidimensional Aptitude 
Battery), and measures of personality (Minnesota Multiphasic Personality Inventory) and 
sociability (Interpersonal Behavior Survey). These tests each require about 45-90 minutes to 
complete and help us better interpret other data collected from you. All psychological and 
behavioral tests will be administered by a trained technician in accordance with standards 
established for test administration, interpretation, and confidentiality by the American 
Psychological Association. All paper-and-pencil testing is conducted in a comfortable, quiet 
room located in the metabolic unit or in the Psychology Laboratory at the GFHNRC. 
Duririg the last week of the study, the research psychologist and other psychology staff 
will meet with you individually, and in groups when appropriate, to present all available 
performance, psychological and electrophysiological data collected from you, to provide 
interpretation of your results when appropriate, and to get your thoughts about the testing done 
by the psychology staff. 
Activity Monitoring: Your daily activity will be measured continuously throughout the 
study by having you wear an activity watch (accelerometer) that counts body movements. You 
may wear the watch above the wrist bone on your <.1ominant or non-dominant hand, with a plastic' 
or elastic band, whichever you chose. 
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Vision and Auditorv Function: During the first two weeks of the study, your vision and 
hearing will be tested by using standard screening equipment and procedures similar to those 
used in testing vision for a driver's license and for testing hearing in e1ementaryschool children. 
These tests require about 30 minutes and are administered by a trained technician in a 
comfortable, quiet room located in the Psychology Laboratory at the GFHNRC. 
Dual X-Rav Absorptiometry: This test is used to assess and describe your body 
composition. Whole body composition is an outcome variable that will be measured during the 
study. Three times during the study, you will go to a laboratory where you will lie on your back 
on a bed that will move over an x-ray source for 20 minutes. One scan of your body ii-om head 
to foot will be performed. For this test you will wear loose fitting clothing that does not contain 
metal. 
Whole-Bodv Scintillation Counting Using a Uniform Iso,tope Source (UNIS): This 
test is also used to assess and describe your body composition. Three times during the study, you 
will have a Uniform Isotope Source (UNIS). Your muscles, organs and bones contain 
potassium-40, a naturally OCCUlTing radioisotope of potassium not found in fat. By counting the 
'potassium-40, we will be able to estimate your fat-free mass and body cell mass and determine 
whether it changes with the boron in the diet. During this whole-body count, you will be 
exposed for approximately one minute to a small amount of radiation from sodium-22 (a 
radioactive form of sodium) contained in a sealed-sheet of plastic (UNIS) under the mattress in 
the whole-body counter. This will permit us to determine your self-absorption of internally-
produced radiation because of your particular body size and shape. Before each whole-body 
count, you will shower, shampoo your hair and put on clothing, which we will supply. A 
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technician will direct you into the whole-body counter steel room where you will lie down on a 
mattress on the counter. During a whole-body count and UNIS, you will stay in the enclosed 
steel room, lying on a bed between two banks of 16 detectors each. You will be observed on a 
closed-circuit TV system, will be able to contact the technician by intercom, and you will have a 
choice of listening to the radio, cassette tape player or having silence. Each whole-body count 
and UNIS will take a total of 10-30 minutes including data processing time. 
Anthropometrv: These measurements are used to evaluate the adequacy of your dietary 
energy intake. Determination of circumferences of the upper arm, calf, thigh and waist, and of 
length measurements at the elbow and the lmee will be made by using a tape measure and an 
anthropometric caliper. Assessments of skinfold thiclmess will be perfOlmed by pinching the 
skin, holding the pinched area, then measuring the thiclmess of the pinched skin and adipose 
tissue at the front and back of your upper arm, back, waist and calf. Standing height and body 
weight will also be determined. These anthropometric measurements will be performed 3 times 
dUling the study. You will wear loose-fitting clothing. 
Bioelectrical Impedance: Measurements are made for validation of this technique to 
predict body composition and fluid distribution in postmenopausal women. Bioelectrical 
impedance measurements performed to determine fat and muscle in the body three times during 
the study. You will lie on a cot and electrodes will be attached to your wrists, ankles, elbows, 
lmees, upper and lower arm, and thigh. A painless, low energy electrical current of 100 
microamps at radio frequencies ranging from 1 kilohertz to 1 megahertz will be applied. This 
radio frequency current is the same amount of electrical current that floats around you while you 
are watching television or listing to the radio. You will not be aware that the electrical current is 
I have read this page and agree with the content __ 
71 
Physiologic Amounts of Dietary Boron as a Factor in the Manifestatiou of Rheumatoid Arthritis 
entering your body. Various measures of how your body conducts this electrical current will be 
determined. You will wear your own shorts and a short sleeved shirt or t-shirt but no shoes or 
socks. 
Do Living Conditions Represent A Risk? 
No, despite the minimal loss of privacy normal in any group living situation and some 
loss of freedom as demanded by the study regime, the Metabolic Unit environment and study 
procedures have been designed so participation does not present any risk to your physical or 
psychological health. To assist in your adjustment to the study and the special demands of group 
living, you will be expected to attend weeldy group meetings with the Metabolic Unit Manager 
and Psychology staff and to periodically meet individually with the Psychologist or a Graduate 
Psychology assistants. 
What Are The Risks Of The Study? 
RA Therapies: The RA therapies that are continued in the study are very specific 
therapies that were either prescribed by a physician or selected by you before entry into the 
study. It is your responsibility to be aware of the positive and negative effects that those 
therapies have on your health. There are no known risks associated with consuming the diet and 
supplements prepared for the study while continuing any of the methotrexate, prednisone, 
nonacetylated salicylates, or hormone replacement therapies (see chart on pages 3-5). Because 
methotrexate interferes with the vitamin, folic acid, extra amounts of folic acid (1 milligram per 
day) will be supplemented to the diet. 
Low Boron Diet: Negative boron balance has been induced experimentally with normal 
~ts that supplied about 0.36 milligram boron daily. Previous studies at the Grand Forks Human 
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Nutrition Research Center (GFHNRC) indicate that persons consuming 0.36 milligram of boron 
daily for about three months, compared to when they received 3.23 milligram of boron daily for 
the same period of time reported no noticeable effects, but did have small but significant 
decreases in systolic and diastolic blood pressure within the physiological range and a lengthened 
segment of the heart beat tracing, and blood and urine biochemical changes. During the boron 
depletion period of this study, you will be consuming about 0.2 milligram of boron daily for 77 
days. 
Symptoms of boron deficiency in humans are not well defined. AssoCiations have been 
made between low boron intake and the incidence of arthritis. Because you will be consuming a 
diet low in boron for part of the study, it is expected that you will show some changes in the 
amounts of boron and minerals, and some organic substances in your blood, urine and stools, and 
increased incidence and severity of signs associated with rheumatoid arthritis, mainly pain and 
inflammation ofthe joints. 
You could also show some small changes in your brain electrical activity or heart beats. 
We anticipate that these changes will not be noticeable to you and will not be health-threatening. 
As a precaution, you will be closely monitored for any severe or health threatening signs of 
boron deprivation (including heart beat changes) and will be supplemented with boron or 
examined by a study physician for complications of rheumatoid arthritis if such signs occur at no 
cost to you. 
There is a small possibility that heart rhythm (your heart beat) change might occur. As 
indicated, your heart will be monitored routinely by a heart beat recorder machine during the 
study. If any abnormalities or significant changes in your heart beats or heart structure occur 
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which indicate that you may become at risk ifthe boron depletion were to be continued, you will 
besupplemented with boron and will stay on the boron supplementation until the end of the 
study. In addition, any other evidence of the possibility of developing severely low boron status 
that could be harmful to you will be cause for stopping boron depletion and starting boron 
supplementation. 
If an RA flare-up occurs, you will be advised to consult your personal physician who is 
familiar with yom arthritis history by phone and/or written correspondence. With yom written 
permission, health-related or pertinent research information collected during the course of the 
study will be provided to the consulting/personal physician. Travel to a consulting/personal 
physician (that may be the same as the study physician) within a 100 mile radius of Grand Forks, 
ND, will be provided by the Research Center. Ifbeyond a 100 mile radius, it will be suggested 
that the physician coordinate with the health care center associated with the study physician. 
With your written permission, your consulting/personal physician will be advised of the RA 
treatments approved tor use during the study. The actual treatment for a specific flare-up may 
include treatments other than those suggested. If the flare-up or treatment interferes with the 
research, you will be dismissed from the study. lfthe flare-up does not interfere with the 
research, then continuation will be at your discretion. 
Experimental Diet: Every effort has been made to plan tasty diets acceptable to you; 
however, you may become tired of consuming the same limited number of foods every third day 
r 168 days. All foods are from local stores, and the foods are prepared in standard ways. 
11)' supplements may be added to ensure that all nutrients (except perhaps boron) are in 
's estimated to be consumed by postmenopausal women near your age. There are no 
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known risks associated with consumption of broccoli grown in a solution containing mainly just 
one natural boron isotope other than possible transient intestinal gas and bloating associated with 
broccoli consumption per se. 
Cardiac Monitoring: There are no known risks associated with heart monitoring or 12-
lead electrocardiograms. However, you may experience some skin irritation from contact with 
the electrodes. 
RA Feature Assessment: All assessments of joint function are expected to cause a 
transient increase in pain in joints with active rheumatoid arthritis. There are no known risks 
associated with determining hand volume by immersion in water. 
Resting Energv Expenditure: There are no lmown risks associated with participating in 
the test to determine how much energy you use up while resting. You may experience some 
minor discomfort with the equipment used to collect your breath. 
Blood Draws: There will be some discomfort as the needle enters your skin. About 10% 
of the time a small bruise (hematoma) develops at the puncture site. Less than 0.1 % of the time 
the site may become infected, but this is easily treated with antibiotics. If an infection develops, 
the GFHNRC will pay for all necessary medical care and attention. A maximum of287 milliliter 
(0.6 pints) will be drawn within an eight-week period. This is considerably less than blood bank 
donation limits of 475 milliliter (1 pint) every eight weeks. 
The initial condition of rheumatoid arthritis sometimes causes slight anemia (less than 10 
grams of hemoglobin per deciliter of blood). A study with men and women with inflammatory 
arthritis found that their hemoglobin values were 12.6 ± 0.6 grams per deciliter of blood. Normal 
hemoglobin for women between 18 and 49 years of age is 12-16 grams per deciliter of blood. 
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The amount of blood that you will give is not likely to markedly affect your iron status. 
However, if your initial hemoglobin is at or above ·l0 grams per deciliter of blood and if the 
removal of blood causes the amount of hemoglobin in your blood to drop below 10 grams per 
deciliter of blood, the amount of blood taken from you will be decreased. Or, if your initial 
hemoglobin is below 10 grams per deciliter of blood and if the removal of blood causes the 
amount of hemoglobin in your blood to drop more than another 10%, the amount of blood taken 
from you will be decreased. If you become very anemic (very iron deficient), you will be sent to 
a local physician at no cost to you. If the physician prescribes iron, you will be provided 
supplements. If you are still iron depleted at the end of the study, three months of iron 
supplements will be given to you to make sure your iron status returns to your usual level. 
Boron Stable Isotope Administration: The procedure of inserting a needle in an arm 
vein which will stay there for 4 hours is similar to that used routinely in hospitals and clinics to 
diagnose diabetes mellitus. There should be minimal risk and discomfort. There is no known 
risk for eating broccoli raised in regular greenhouse in a mineral water solution. 
Urine and Stool Collection: There are no known risks associated with this procedure. 
There may be odors from the urine and stool collections. This can be minimized by keeping the 
samples cool in the refrigerator in your bathroom. 
Brain Function: There are no known risks associated with the electroencephalogram or 
the collection of other electrophysiologic data related to polysomnography. However, you may 
experience mild, transient discomfort during electrode placement on or removal from the scalp, 
face, neck and legs. 
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Psvchological and Behavioral Function: There are no known risks or discomforts 
associated with assessment of sensory-motor and spatial skills, cognitive processes, motor 
tremor, mood states, or other behaviors and symptoms assessed by questionnaires. If you have 
any concerns regarding psychological and behavioral assessments, you may discuss these with 
the psychologist or psychology research assistants (supervised by a licensed clinical 
psychologist), with whom ·you will be meeting on a regular basis. 
Activity Monitoring; There are no known risks or discomforts associated with activity 
monitoring. 
Vision and Auditorv Function: There are no known risks or discomforts associated with 
the vision or hearing tests. 
Dual X-Rav Absorptiometrv and Whole-Body Scintillation Counting.;. Exposure to 
radiation is often expressed in terms ofrem or millirem (one thousandth ofa rem). By 
participating in this study, the total amount of extra whole body radiation you will receive is 
approximately 1.5 millirem, or about a half of 1 % of the average annual radiation exposure of 
360 millirem per person in the U.S. This amount of total radiation is less than 15% of a routine 
chest x-ray. It is equivalent to spending 8 hours in a jetliner at cruising altitude or spending 
approximately 1.5 weeks in the Colorado plateau area. It is about equal to radiation exposure 
from cosmic rays at sea level for 3 weeks. Two concerns about radiation are that it can cause 
cancer or shorten life. Estimates of the risk of radiation have been based mainly on very high 
radiation exposures of Japanese survivors of World War II atomic bombs. If the effect of 
radiation at high doses is assumed to be proportional to the effect at low doses, the radiation 
exposure received in this study could result in 0.125 "extra" cancer deaths per 100,000 people 
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and reduce life span by an average of 11.5 minutes per person. However, it is impossible to 
accurately estimate the excess deaths because the exposure form participating in tlus study is 
insignificant when compared to a person's lifetime exposure of about 24,000 milligrems from 
natural' sources such as cosmic rays and radon. 
Anthropometrv and Skinfold Thickness Measurements: There are no known risks 
involved in the anthropometric and skinfold thickness measurements. Some individuals, 
however, may experience transient, minor discomfort during the measurement of skinfold 
thickness. 
Bioelectrical Impedance: There are no known biological or health hazards associated 
with the method and procedure to be used to measure how your body conducts an applied, non 
perceptible, low level, safe electrical current. 
Adverse Reactions or Health Problems: Adverse reactions are unlikely, and but could 
include problems such as food intolerance, faintness with blood draws, or common health care 
problems unrelated to the research, such as infectious illnesses, muscle strain, physical injuries, 
or previously unrecognized health problems. Any detected difficulties will be discussed with 
you individually. You may be advised to consult with a local physician, at the expense of the 
research center if related to the research or at your own expense if unrelated to the research. If 
we ilutiate the medical consultation, we will pay transp0l1ation costs within a 1 OO-mile radius of 
the Center. If you are unwilling to see a physician within that 100-n1ile radius limit, you will 
most likely be dismissed from the study. No health-related information will be provided to a 
health care center without your express written consent. If the problem interferes with the 
research, or if you no longer qualify under the medical or RA treatment criteria, then you will be 
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dismissed from the study. lfthe problem does not interfere with the research, then continuation 
will be at your discretion. Temporary changes in procedures (e.g. missed or delayed meals or 
testing) may be possible if they do not interfere with the main objective of the research, but you 
will always have the option to withdraw. 
How Are Emergencies Handled? 
A nurse is on the Unit twenty-four hours a day, seven days a week. A physician is on 
staff. The nurses are CPR certified and the physician is certified in Advance Cardiac Life 
Support. The Altru Health System's ambulance (located 1 mile away) will be called for 
emergency medical care. First aid supplies and a fire extinguisher are on the Unit. Policies and 
procedures for Emergency Response (including fire, bomb threats, and tornado) are in place. 
Are There Benefits To Taking Part In This Studv? 
Direct benefits include the satisfaction from participating in a wOlihwhile research study 
that will benefit humanity because it will advance knowledge about the importance of boron for 
health and well being, especially as it relates to the control of rheumatoid arthritis. Iriformation 
may be used to plan better diets or to change the dietary recommendations for boron. In 
appreciation for your participation, you will receive $35 per day to be paid every two weeks. 
The total amount of the honorarium that you will receive if you complete the study will be 
$5,880. 
What Other Choices Do! Have If! Don't Take Part In This Study? 
This study is being done only to gather research information. You may choose not to 
take part in this study. 
What Are The Costs Of Tests And Procedures? 
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We do not expect that you will have to pay any money if you are in this study. There are 
no additional costs to you as a result of participating in the study. 
What if I Decide Later Not To Take Part In This Studv? 
You are free to leave this study at any time; however, if you leave early for any reason, 
you forfeit any unearned stipend. We reserve the right to dismiss you at any time if, in our 
opinion, you have disobeyed regulations, have disrupted research or have exhibited inappropriate 
behavior. If it is felt that continuing in the study might be harmful to you physically or mentally, 
or if there is the development of an illness or a condition that might affect research results, you 
will be dismissed E:om the study. Regardless of the reason for leaving the study, you will receive 
the honorarium to the day of discharge. Early dismissal or withdrawal from the study will not be 
held against you by the University of North Dakota, the U.S. government, nor your personal 
physician . 
. What Happens If I Am Injured Because I Took Part In This Study? 
If you are injured while participating in this study as a result of the negligence of an 
involved United States Government employee, you may be able to receive compensation for your 
injury in accordance with the requirements of the Federal Tort Claims Act. Compensation from 
individuals or organizations other than the United States might also be available to you. If you 
are a federal employee acting within the scope of your employment, you may be entitled to 
benefits in accordance with the Federal Employees Compensation Act. 
During your participation in this nutritional study, medical care will be available from 
physicians in the local community. You are responsible for any· and all expenses related to 
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medial care involved with health problems, including rheumatoid arthritis, whose cause and 
origin predate entry into this study. Other routine medical expenses incurred to maintain your 
health during your participation in the experimental protocol will be provided without cost to 
you. Because of the lack of total health care coverage, you are strongly encouraged to maintain 
any personal health care insurance throughout the time of your participation. 
You can get more information on our policies, the conduct ofthis study, and your 
rights as a research subject by calling Dr Curtiss Hunt at 701-795-8423. 
What About Confidentiality'? 
All in:formation about you (other than your name, address and social security number 
which are needed to prepare your IRS Form 1099) is confidential. We do not withhold income, 
social security or unemployment taxes because we do not consider you to be an employee. 
To keep your research data confidential, you will be assigned an identification number 
which will be used to anonymously code your research data for computer entry. Paper copies of 
your personal information and medical data will be kept in a locked file, with access limited to 
approved staff members. Your signed consent form will be kept in a locked file for at least 3 
years, and our current policy is to keep them indefinitely. If and when they are disposed of, your 
name and any identifying information will be shredded. Any results from your participation in 
this project may be published in a scientific journal, but only in a fOlm not identifiable with you. 
At the conclusion of your participation in the study, you may request that copies or 
summaries of your test results be sent to a qualified professional for interpretation and review 
with you at your own expense. A fee may be charged to cover reproduction expenses if large 
quantities of data are requested. 
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Who Can Answer Mv Questions? 
You are free to ask questions at any time during the study by calling Dr. Curtiss Hunt at 
701-795-8423 or -8353, Dr. James Penland at 701-795-8471 or -8353, Dr. Joseph Sleckman at 
701-280-8900, or Dr. Hemy Lukaski at 701-795-8429 or -8353, or by talking to any staff 
member. 
I Agree To Take Part In This Study. 
I have been given a signed copy of this form. My signature below signifies that I have 
read this form, have had the study explained, have had any questions answered to my 
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APPENDIXD 
VERBAL COMMANDS FOR RANGE OF MOTION ASSESSMENT 
For the following measurements, a pressure of moderate intensity will be applied to 
subjects for consistent readings in measurements. Deviating from standard range of 
motion measurement procedures, if hypermobility exists measurements will be taken 
from the palmar surface of the digit. 
FIRST DIGIT MEASUREMENTS 
MPFlexion 
Testing position: Weight of the hand will rest on the 5th metacarpal and 
phalange, with wrist in neutral position. 
Verbal cues: "Bend your thumb as far as you can, like this." 
Demonstration provided by tester. "Can you go any further?" 
MP Extension 
Testing position: Weight of the hand will rest on the 5th metacarpal and 
phalange, with wrist in neutral position. 
Verbal cues: "Straighten your thumb as far as you can like this." 
Demonstration provided by tester. "Can you go any further?" 
IP Flexion 
Testing position: Weight of the hand will rest on the 5th metacarpal and 
phalange, with wrist in neutral position. 
Verbal cues: "Bend your thumb as far as you can, like this." 
Demonstration provided by tester. "Can you go any further?" 
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IP Extension 
Testing position: Weight of the hand will rest on the 5th metacarpal and 
phalange, with wrist in neutral position. 
Verbal cues: "Straighten your thumb as far as you can like this." 
Demonstration provided by tester. "Can you go any further?" 
SECOND THROUGH FIFTH DIGITS' MEASUREMENTS 
MPFlexion 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 55 degrees elbow flexion, 45 degrees wrist 
pronation, with the palmar surface of the hand resting on the table. 
Verbal cues: "Bend your finger down toward the ground like this." 
Demonstration provided. "Can you go any further?" 
MP Extension 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 55 degrees elbow flexion, 45 degrees wrist 
pronation, with the palmar surface of the hand resting on the table. 
Verbal cues: "Straighten your finger towards the ceiling as far as you can 
go." Demonstration provided. "Can you go any further?" 
PIP Flexion 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 105 degrees of elbow flexion, wrist in neutral 
position, with the dorsum of hand facing tester. 
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Verbal cues: "Bend your middle knuckle as far as you can. Be careful not 
to inhibit your ROM by stopping when you come in contact with your 
palm." Demonstration provided by tester. "Can you go any further?" 
PIP Extension 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 105 degrees of elbow flexion, wrist in neutral 
position, with the dorsum of hand facing tester. 
Verbal cues: "Straighten your finger as much as you can." Demonstration 
provided. "Can you go any further?" 
DIP Flexion 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 105 degrees of elbow flexion, wrist in neutral 
position, with the dorsum of hand facing tester. 
Verbal cues: "Bend the knuckle closest to the tip of your finger as far as 
you can. Be careful not to inhibit your ROM by stopping when you come 
in contact with your finger." Demonstration provided by tester. "Can you 
go any further?" 
DIP Extension 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 105 degrees of elbow flexion, wrist in neutral 
position, with the dorsum of hand facing tester. 
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Verbal cues: "Straighten your finger as much as you can." Demonstration 
provided. "Can you go any further?" 
WRIST MEASUREMENTS 
Flexion 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 55 degrees elbow flexion, 45 degrees wrist 
pronation, with the hand resting off the edge of the table, just proximal to 
the ulnar styloid process. 
Verbal cues: "Bend your wrist down towards the floor as far as you can 
go, keeping your fingers straight." Demonstration provided. "Can you go 
any further?" 
Extension 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 55 degrees elbow flexion, 45 degrees wrist 
pronation, with the hand resting off the edge of the table, just proximal to 
the ulnar styloid process. 
Verbal cues: "Can you bend your wrist up to the ceiling as far as you can 
with your fingers straight." Demonstration provided by tester. "Can you 
go any further?" 
Ulnar Deviation 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 55 degrees elbow flexion, 45 degrees wrist 
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pronation, with the hand resting off the edge of the table, just proximal to 
the ulnar styloid process. 
Verbal cues: "Can you move your hand as far as you can to the side of 
your little finger moving at the wrist joint only." Demonstration provided 
by tester. "Can you go any further?" 
Radial Deviation 
Testing position: Arm placed in approximately 10 degrees of shoulder 
flexion and abduction, 55 degrees elbow flexion, 45 degrees wrist 
pronation, with the hand resting off the edge of the table, just proximal to 
the ulnar styloid process. 
Verbal cues: "Can you move your hand as far as you can to the side of 
your thumb moving at the wrist joint only." Demonstration provided by 
tester. "Can you go any further?" 
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APPENDIXE 
POL Y ARTHRITIS ASSESSlVIENT 
Patient's Name Assessment Date 
--------------------~ ----------
Duration of morning stiffuess, in hours _______ _ 
Number of active joints _____ _ 
Please indicate on the diagram below by placing an '')('' or a circle in the area in which 
you are feeling activity within the joint. 
Active Joints 
Joint Pain Now (Circle number): 
No Pain: 0-1-2--3 4 5-6-7-8-9-10: Worst Possible Pain ..: 
"Fibromyalgic" Point Count 
Point Count 
RIahC ld 
Total (of 18) ---
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